National Academies Press: OpenBook

Biologic Markers in Pulmonary Toxicology (1989)

Chapter: References

« Previous: 7 Conclusions and Recommendations
Suggested Citation:"References." National Research Council. 1989. Biologic Markers in Pulmonary Toxicology. Washington, DC: The National Academies Press. doi: 10.17226/1216.
×
Page 137
Suggested Citation:"References." National Research Council. 1989. Biologic Markers in Pulmonary Toxicology. Washington, DC: The National Academies Press. doi: 10.17226/1216.
×
Page 138
Suggested Citation:"References." National Research Council. 1989. Biologic Markers in Pulmonary Toxicology. Washington, DC: The National Academies Press. doi: 10.17226/1216.
×
Page 139
Suggested Citation:"References." National Research Council. 1989. Biologic Markers in Pulmonary Toxicology. Washington, DC: The National Academies Press. doi: 10.17226/1216.
×
Page 140
Suggested Citation:"References." National Research Council. 1989. Biologic Markers in Pulmonary Toxicology. Washington, DC: The National Academies Press. doi: 10.17226/1216.
×
Page 141
Suggested Citation:"References." National Research Council. 1989. Biologic Markers in Pulmonary Toxicology. Washington, DC: The National Academies Press. doi: 10.17226/1216.
×
Page 142
Suggested Citation:"References." National Research Council. 1989. Biologic Markers in Pulmonary Toxicology. Washington, DC: The National Academies Press. doi: 10.17226/1216.
×
Page 143
Suggested Citation:"References." National Research Council. 1989. Biologic Markers in Pulmonary Toxicology. Washington, DC: The National Academies Press. doi: 10.17226/1216.
×
Page 144
Suggested Citation:"References." National Research Council. 1989. Biologic Markers in Pulmonary Toxicology. Washington, DC: The National Academies Press. doi: 10.17226/1216.
×
Page 145
Suggested Citation:"References." National Research Council. 1989. Biologic Markers in Pulmonary Toxicology. Washington, DC: The National Academies Press. doi: 10.17226/1216.
×
Page 146
Suggested Citation:"References." National Research Council. 1989. Biologic Markers in Pulmonary Toxicology. Washington, DC: The National Academies Press. doi: 10.17226/1216.
×
Page 147
Suggested Citation:"References." National Research Council. 1989. Biologic Markers in Pulmonary Toxicology. Washington, DC: The National Academies Press. doi: 10.17226/1216.
×
Page 148
Suggested Citation:"References." National Research Council. 1989. Biologic Markers in Pulmonary Toxicology. Washington, DC: The National Academies Press. doi: 10.17226/1216.
×
Page 149
Suggested Citation:"References." National Research Council. 1989. Biologic Markers in Pulmonary Toxicology. Washington, DC: The National Academies Press. doi: 10.17226/1216.
×
Page 150
Suggested Citation:"References." National Research Council. 1989. Biologic Markers in Pulmonary Toxicology. Washington, DC: The National Academies Press. doi: 10.17226/1216.
×
Page 151
Suggested Citation:"References." National Research Council. 1989. Biologic Markers in Pulmonary Toxicology. Washington, DC: The National Academies Press. doi: 10.17226/1216.
×
Page 152
Suggested Citation:"References." National Research Council. 1989. Biologic Markers in Pulmonary Toxicology. Washington, DC: The National Academies Press. doi: 10.17226/1216.
×
Page 153
Suggested Citation:"References." National Research Council. 1989. Biologic Markers in Pulmonary Toxicology. Washington, DC: The National Academies Press. doi: 10.17226/1216.
×
Page 154
Suggested Citation:"References." National Research Council. 1989. Biologic Markers in Pulmonary Toxicology. Washington, DC: The National Academies Press. doi: 10.17226/1216.
×
Page 155
Suggested Citation:"References." National Research Council. 1989. Biologic Markers in Pulmonary Toxicology. Washington, DC: The National Academies Press. doi: 10.17226/1216.
×
Page 156
Suggested Citation:"References." National Research Council. 1989. Biologic Markers in Pulmonary Toxicology. Washington, DC: The National Academies Press. doi: 10.17226/1216.
×
Page 157
Suggested Citation:"References." National Research Council. 1989. Biologic Markers in Pulmonary Toxicology. Washington, DC: The National Academies Press. doi: 10.17226/1216.
×
Page 158
Suggested Citation:"References." National Research Council. 1989. Biologic Markers in Pulmonary Toxicology. Washington, DC: The National Academies Press. doi: 10.17226/1216.
×
Page 159
Suggested Citation:"References." National Research Council. 1989. Biologic Markers in Pulmonary Toxicology. Washington, DC: The National Academies Press. doi: 10.17226/1216.
×
Page 160
Suggested Citation:"References." National Research Council. 1989. Biologic Markers in Pulmonary Toxicology. Washington, DC: The National Academies Press. doi: 10.17226/1216.
×
Page 161
Suggested Citation:"References." National Research Council. 1989. Biologic Markers in Pulmonary Toxicology. Washington, DC: The National Academies Press. doi: 10.17226/1216.
×
Page 162
Suggested Citation:"References." National Research Council. 1989. Biologic Markers in Pulmonary Toxicology. Washington, DC: The National Academies Press. doi: 10.17226/1216.
×
Page 163
Suggested Citation:"References." National Research Council. 1989. Biologic Markers in Pulmonary Toxicology. Washington, DC: The National Academies Press. doi: 10.17226/1216.
×
Page 164
Suggested Citation:"References." National Research Council. 1989. Biologic Markers in Pulmonary Toxicology. Washington, DC: The National Academies Press. doi: 10.17226/1216.
×
Page 165
Suggested Citation:"References." National Research Council. 1989. Biologic Markers in Pulmonary Toxicology. Washington, DC: The National Academies Press. doi: 10.17226/1216.
×
Page 166

Below is the uncorrected machine-read text of this chapter, intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text of each book. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

References Abraham, J. L. 1978. Recent advances in pneumoconio- sis: The pathologists role in etiologic diagnosis, pp. 96 - 137. In W. M. Thurlbeck and M. R. Abell, Eds. Lung: Structure, Function, and Disease. Baltimore: Williams and WiLkins. Adamson, I. Y., and D. H. Bowden. 1986. Crocidolite-in- duced pulmonary fibrosis in mice. Cytokinetic and biochemical studies. Am. J. Pathol. 122:261 - 267. Adriaenssens, P. I., C. M. White, and M. W. Anderson. 1983. Dose-response relationships for the binding of benzo~a~pyrene metabolites to DNA and protein in lung, liver, and forestomach of control and butylated hydroxyanisole-treated mice. Cancer Res.43:3712- 3719. Agnew, J. E. 1984. Aerosol contributions to the inves- tigation of lung structure and ventilatory function, pp. 92 - 126. In S. W. Clarke and D. Pavia, Eds. Aerosols and the Lung: Clinical and Experimental Aspects. London: Butterworths. Agnew, J. E., D. Pavia, and S. W. Clarke. 1981. Airways penetration of inhaled radioaerosol: An index to small airways function? Eur. J. Respir. Dis. 62:239 - 255. Agnew, J. E., P. P. Sutton, D. Pavia, and S. W. Clarke. 1986. Radioaerosol assessment of mucociliary clear- ance: Towards definition of a normal range. Br. J. Radiol. 59:147 - 151. Ahmed, I. H., E. El-Khatib, J. W. Logus, G. C. W. Man, J. Jacques, and S. F. P. Man. 1986. Altered pulmonary epithelial permeability in canine radiation lung injury. J. Appl. Physiol. 61:971 - 981. Albert, R. E., and L. C. Arnett. 1955. Clearance of radioactive dust from the human lung. AMA Arch. Ind. Health 12:99 - 106. Albert, R. E., J. R. Spiegelman, M. Lippmann, and R. Bennett. 1968. The characteristics of bronchial clear- ance in the miniature donkey. Arch. Environ. Health 17:50 - 58. Albert, R. E., M. Lippmann, and W. Briscoe. 1969. The characteristics of bronchial clearance in humans and the effects of cigarette smoking. Arch. Environ. Health 18:738 - 755. Albert, R. E., M. Lippmann, H. T. Peterson, Jr., J. Berger, K. Sanborn, and D. E. Bohning. 1973. Bronchial 137 deposition and clearance of aerosols. Arch. Intern. Med. 131:115 - 127. Albert, R. E., J. Berger, K. Sanborn, end M. Lippmann. 1974. Effects of cigarette smoke components on bronchial clearance in the donkey. Arch. Environ. Health 29:96 - 101. Albertini, R. J. 1980. Drug-resistant lymphocytes in man as indicators of somatic cell mutation. Teratogen- esis Carcinog. Mutagen. 1:25 - 48. Alpert, S. M., B. B. Schwartz, S. D. Lee, and T. R. Lewis. 1971. Alveolar protein accumulation. Arch. Intern. Med. 128:69 - 73. Altshuler, B., E. D. Palmes, L. Yarmus, and N. Nelson. 1959. Intrapulmonary mixing of gases studied with aerosols. J. Appl. Physiol. 14:321 - 327. American Thoracic Society. 1986. Evaluation of impair- ment/disability secondary to respiratory disorders. Am. Rev. Respir. Dis. 133:1205 - 1209. AmericanThoracicSociety. 1987. Single-breath carbon monoxide diffusing capacity (transfer factor): Recom- mendations for a standard technique. Am. Rev. Res- pir. Dis. 136:1299 - 1307. Amoruso, M. A., G. Witz, and B. D. Goldstein. 1981. Decreased superoxide anion radical production by rat alveolar macrophages following inhalation of ozone or nitrogen dioxide. Life Sci. 28:2215 - 2221. Amrein, R., R. Keller, H. Joos, and H. Herzog. 1970. New theoreticalvalues in exploration of the respiratory function of the lung. Bull. Physiopathol. Respir. (Nancy) 6:317 - 349. Andersen, M. E. 1981. A physiologically teased toxico- kinetic description of the metabolism of inhaled gases end vapors: Analysis at steady state. Toxicol. Appl. Pharmacol. 60:509 - 526. Andersen, M. E., and J. C. Ramsey. 1983. A physiology icaltrbased dragon of the inhalation pharmaco~n~ tics of styrene in rats and humans. Dev. Toxicol. Environ. Sci. 11:415 - 418. Andersen, M. E., H. J. Clewell, M. L. Gargas, F. A. Smith, end R. H. Reitz. 1987. Physiologicallybasedpharm- aco~netics and the rick assessment process for methy- lene chloride. To~col. Appl. Pharmacol. 87:185 - 205. Anderson, H. A. 1985. Utilization of adipose tissue biopsy in characterizing human halogenated hydrocar

138 bon exposure. Environ. Health Perspect. 60:127 - 131. Anthonisen, N. R., J. Danson, P. C. Robertson, and W. R. D. Ross. 1969. Airway closure as a function of age. Respir. Physiol. 8:58 - 65. Appleton, B. S., M. P. Goetchius, and T. C. Campbell. 1982. Linear dose-response curve for the hepatic macromolecular binding of aflatoxin Be in rats at very low exposures. Cancer Res. 42:3659 - 3662. Ashby, J. 1982. Screening chemicals for mutagenicity Practices and pitfalls, pp.1 - 33. In J. A. Heddle, Ed. Mutagenicity: New Horizons in Genetic Toxicology. New York: Academic Press. Au, W. W., P. Bibbin$ J. B. Ward, Jr., and M. S. [orator. 1988. Development of a rodent lung macrophage chromosome aberration assay. Mutat. Res.208:1 - 7. Aubas, P., B. Cosso, P. Godard, F. B. Michel, and J. Clot. 1984. Decreased suppressor cell activity of alveolar macrophages in bronchial asthma. Am. Rev. Respir. Dis. 130:875 - 878. Ayers, L. N., M. L. Ginsberg, J. Fein, and K Wasserman. 1975. Diffusing capacity, specific diffusing capacity and interpretation of diffusion defects. West. J. Med. 123:255 - 264. Babior, B. M. 1978. O'ygen-dependent microbial king by phagocytes. N. Engl. J. Med. 298:659 - 668. Bailey, M. R., F. A. Fry, and A. C. James. 1982. The long-term clearance kinetics of insoluble particles from the human lung. Ann. Occup. Hyg. 26:273 - 290. Bailey, M. R., A. Hodgson, and H. Smith. 1985. Respira- to~y tract retention of relatively insoluble particles in rodents. J. Aerosol Sci. 16:279 - 293. Baker, R. M., D. M. Burnette, R. Mankovitz, L. H. Thompson, G. F. Whitmore, L. Siminovitch, and M. J. Till. 1974. Ouabain-resistant mutants of mouse and hamster cells in culture. Cell 1:9 - 21. Bang, B. G., A. L. Mukherjee, and F. B. Bang. 1967. Human nasal mucus flow rates. Johns Hopkins Med. J. 121:38 - 48. Bang, F. B., and M. Foard. 1964. Interaction of respira- tory epithelium of the chick and Newcastle disease virus. Am. J. Hyg. 79:260 - 278. Bargon, J., H. Kronenberger, L. Bergmann, R. Buhl, J. Meier-Sydow, and P. Mitrou. 1986. Lymphocyte transformation test in a group of foundry workers exposed to beryllium and non-exposed controls. Eur. J. Respir. Dis. 146(Suppl.~:211 - 215. Barnes, P. J., and M. J. Brown. 1981. Venous plasma histamine in exercise- and hyperventilation-induced asthma in man. Clin. Sci. 61:159 - 162. Barrett, A. J. 1977a. Cathepsin B and other proteinases, pp. 181 - 208. In A. J. Barrett, Ed. Proteinases in Mammalian Cells and Tissues. Research Monographs in Cell and Tissue Physiology, Vol. 2. Amsterdam: North-Holland. Barrett, A. J. 197 7b. Cathepsin D and other proteinases, pp. 209 - 248. In A. J. Barrett, Ed. Proteinases in Mammalian Cells and Tissues. Research Monographs in Cell and Tissue Physiology, Vol. 2. Amsterdam: North-Holland. REFERENCES Barrow, C. S., W. H. Steinhagen, and J. C. F. Chang. 1983. Formaldehyde sensory irritation, pp. 16 - 25. InJ.E.Gibson,Ed. Formaldehyde Toxicitv. Washin~- ton, D.C.: Hemisphere. -=, Barry, B. E., and J. D. Crapo. 1985. Applications of morphometric methods to study diffi,se and focal injury in the lung caused by toxic agents. CRC Crit. Rev. Toxicol. 14:1 - 32. Barter, C. E., and A. H. Campbell. 1976. Relationship of constitutional factors and cigarette smoking to decrease in 1-second forced expiratoryvolume. Am. Rev. Respir. Dis. 113:305 - 314. Bascom, R., M. Wachs, R. M. Naclerio, U. Pipkorn, S. J. Galli, and L. M. Lichtenstein. 1988. Basophil influx occurs after nasal antigen challenge: Effects of topical corticosteroid pretreatment. J. Allergy Clin. Immunol. 81:580~589. Bates, D. V. 1989. Respiratory Function in Disease, 3rd ed. Philadelphia: W. B. Saunders. 558 pp. Baudendistel, L. J., J. B. Shields, and D. L. Kiminski. 1982. Comparisons of double indicator thermodilution measurements of extravascular lung wafer (EVLW) with radiographic estimation of lungwater in trauma patients. J. Trauma 22:983 - 988. Bauer, M. A., M. J. Utell, P. E. Morrow, D. M. Speers, and F. R. Gibb. 1986. Inhalation of 030 ppm nitrogen dioxide potentiates exercise-induced bronchospasm in asthmatics. Am.Rev. Respir. Dis.134:1203 - 1208. Bauer, W., M. K Gorny, H. R. Baumann, and A. Morell. 1985. T-lymphocyte subsets and immunoglobulin concentrations in bronchoalveolar ravage of patients with sarcoidosis and high and low intensity alveolitis. Am. Rev. Respir. Dis. 132:106~1065. Baughman, R. P., C. H. Bosken, R. G. Loudon, P. Hur- tubise, and T. Wesseler. 1983. Quantitation of bron- choalveolar ravage with methylene blue. Am. Rev. Respir. Dis. 128:266 - 270. Baughman, R. P., S. Strohofer, and C. K. Kim. 1986a. Variation of differential cell counts of bronchoalveolar ravage fluid. Arch. Pathol. Lab. Med. 110:341 - 343. Baughman, R. P., B. C. Corser, S. Strohofer, and D. Hendricks. 1986b. Spontaneous hydrogen peroxide release from alveolar macrophages of some cigarette smokers. J. Lab. Clin. Med. 107:233 - 237. Baumgarten, C. R., A. G. Togias, R. M. Naclerio, L. M. Lichtenstein, P. S. Norman, and D. Proud. 1985. Lnflux of kininogens into nasal secretions after antigen challenge of allergic individuals. J. Clin. Invest. 76:191 - 197. Beck, B. D., J. D. Brain, and D. E. Bohannon. 1981. The pulmonary toxicity of an ash sample from the Mt. St. Helens volcano. Exp. Lung Res.2:289 - 301. Beck, B. D., J. D. Brain, and D. E. Bohannon. 1982. An in vivo hamster bioassay to assess the toxicity of particles for the lungs. Toxicol. Appl. Pharmacol. 66:9 - 29. Beck, B. D., H. A. Feldman, J. D. Brain, T. J. Smith, M. Hallock, and B. Gerson. 1987. The pulmonary toxicity of talc and granite dust as estimated from

REFERENCES anin vim hamster bioassay. ToxicoL Appl. PharmacoL 87:222 - 234. Beer, D. J., S. Matloff, and R. E. Rocklin. 1984. The influence of histamine on immune and inflammatory responses. Adv. Immunol. 35:209 - 268. Begin, R., M. Rola-Pleszczynski, S. Masse, D. Nadeau, and G. Drapeau. 1983. Assessment of progression of asbestosis in the sheep model by bronchoalveolar ravage and pulmonary function tests. Thorax 38:449 - 457. Belinsky, S. A., and M. W. Anderson. 1987. Tissue and cellular specificity for DNA adduct formation and persistence following in viva exposure to chemicals. Prog. Exp. Tumor Res. 31:11 - 20. Bell, D. Y., and G. E. R. Hook. 1979. Pulmonary al- veolar proteinosis: Analysis of airway and alveolar proteins. Am. Rev. Respir. Dis. 119:979 - 990. Bell, D. Y., J. A. Haseman, A. Spock, G. McLennan, and G. E. R. Hook. 1981. Plasma proteins of the bronchoalveolar surface of the lungs of smokers and nonsmokers. Am. Rev. Respir. Dis. 124:72 - 79. Bellanti J. A., Ed. 1985. Immunology m. Philadelphia Saunders. 598 pp. Benson, J. M., R. F. Henderson, R. O. McClellan, R. L. Hanson, and A. H. Rebar. 1986. Comparative acute toxicity of four nickel compounds to F344 rat lung. Fundam. Appl. Toxicol. 7:340 - 347. Berend, N. 1982. The correlation of lung structurewith function. Lung 160:115 - 130. Berend, N., J. L. Wright, W. M. ~urIbe~, G. E. Marlin, and A. J. Woolcock. 1981a. Small airways disease: Reproducibility of measurements and correlation with lung function. Chest 79:263 - 268. Berend, N., C. Skoog, and W. M. Thurlbeck. 1981b. Single-breath nitrogen test in excised human lungs. J. Appl. Physiol. 51:1568 1573. Bevilacqua, M. P., J. S. Prober, M. E. Wheeler, R. S. Cotran, and M. A. Gimbrone, Jr. 1985. Interleukin-1 acts on cultured human vascular endothelium to in- crease the adhesion of polymorphonuclear leukocytes, monocytes, and related leukocyte cell lines. J. Clin. Invest. 76:2003 - 2011. Bhalla, D. K., and T. T. Cracker. 1986. Tracheal per- meability in rats exposed to ozone: An electron micro- scopic and autoradiographic analysis of the transport pathway. Am. Rev. Resp. Dis. 134:572 - 579. Bhalla, D. K., R. C. Mannix, M. T. Kleinman, and T. T. Cracker. 1986. Relative permeability of nasal, tracheas and bronchoalveolar mucosa to macromole- cules in rats exposed to ozone. J. Toxicol. Environ. Health 17:269 - 283. Bice, D. E. 1985. Methods and approaches for assessing immunotoxocity of the lower respiratory tract, pp. 14S-157. In J. Dean, M. I. Luster, A. E. Munson, and H. Amos, Eds. Immunotoxicology and Immuno- pharmacology. Target Organ Toxicology Series. New York: Raven Press. Bice, D. E., and B. A. Muggenburg. 1986. Localized stimulation of memory cells in secondary lung immune 139 responses. Am. Rev. Respir. Dis. 133~4 Pt. 23:A97. (Abstract.) Bice, D. E., D. L. Harris, J. O. Hill, B. A. Muggenburg, and R. K Wolff. 1980a. Immune responses after localized lung immunization in the dog. Am. Rev. Respir. Dis. 122:755 - 760. Bice, D. E., D. L Hams, and B. A. Muggenburg. 1980b. Regional immunologic responses followinglocalized deposition of antigen in the lung. limp. Lung Res. 1:33 - 41. Bice, D. E., M. A. Degen, D. L. Harris, and B. A. Mug- genburg. 1982. Recruitment of antibody-forming cells in the lungs after local immunization is nonspe- cif~c. Am. Rev. Respir. Dis. 126:635 - 639. Bignon, J., P. Chahinian, G. Feldmann, and C. Sapin. 1975. Actual immunoper~dase demonstration of autologous albumin in the alveolar capillary mem- brane and in the alveolar lining material in normal rats. J. Cell. Biol. 64:503 - 509. Bignon, J., M. C. Jaurand, P. Sebastien, and G. Dufour. 1983. Interactions of pleural tissue and cells with mineral fibers, pp. 198 - 207. In J. Chretien and A. Hirsch, Eds. Diseases of the Pleura. New York: Masson. Bitterman, P. B., S. Adelberg, and R. G. CIystal. 1983. Mechanisms of pulmonary fibrosis. Spontaneous release of the alveolar macrophag~derived growth factor in the interstitial lung disorders. J. Clin Invest. 72:1801 - 1813. Bitterman, P. B., M. D. Wewers, S. I. Rennard, S. Adel- berg, and R. G. Crystal. 1986. Modulation of alveolar macrophage-driven f~broblast proliferation tyalternat*emacrophage mediators. J. Clin. Invest. 77:700 708. Block, E. R., and A. B. Fisher. 1977. Depression of serotonin clearance by rat lungs during oxygen ex- posure. J. Appl. Physiol. 42:33 - 38. Bloom, A. D., and N. W. Paul, Eds. 1981. Guidelines for Studies of Human Populations Exposed to Muta- genic and Reproductive Hazards. Proceedings of a conference held January 26 27 in Washington, D.C. White Plains, N.Y.: March of Dimes Birth Defects Foundation. Bohning, D. E., H. L. Atkins, and S. H. Cohn. 1982. Long-term particle clearance in man: Normal and impaired. Ann. Occup. Hyg. 26:259 - 271. Bond, J. A., M. M. Butler, M. A. Medinsky, B. A. Mug- genburg, and R 0. McClellan. 1984. Dog pulmonary macrophage metabolism of free and particle-associated (TIC) benzotaipyrene. J. Toxicol. Environ. Health 14:181 - 189. Bond, J. A., A. R. Dahl, R. F. Henderson, J. S. Dutcher, J. L. Mauderly, and L. S. Birnbaum. 1986. Species differences in the disposition of inhaled butadiene. Toxicol. Appl. Pharmacol. 84:617 - 627. Bond, J. A., R. K. Wolff, J. R. Harkema, J. L. Mauderly, R. F. Henderson, W. C. Griffith, and R. O. McClellan. 1988. Distribution of DNA adducts in the respiratory tract of rats exposed to diesel exhaust. Toxicol. Appl.

140 Pharmacol. 96:336 - 346. Bocij-Noord, H., N. G. M. Orie, and K. De Vries. 1971. Immediate and late bronchial obstructive reactions to inhalation of house dust and protective effects of disodium cromoglycate and prednisolone. J. Allergy Clin. Immunol. 48:344 - 354. Booker, D. V., A. C. Chamberlain, J. Rundo, D. C. F. Muir, and M. L. Thomson. 1967. Elimination of 5-mu particles from the human lung. Nature 215~96~:30-33. Boucher, R. C. 1980. Chemical modulation of airway · epithelialpermeability. Environ. Health Perspect. 35:3 - 12. Boucher, R. C. 1981. Mechanisms of pollutant-induced airways toxicity. Clin. Chest Med. 2:377 - 392. Boucher, R. C., V. Ranga, P. D. Pare, L. A. Moroz, and J. C. Hogg. 1977a. The effect of allergic bronchocon- striction on respiratory mucosalpermeability. Physiolo- gist 20~4~:11. (Abstract.) Boucher, R. C., P. D. Pare, N. J. Gilmore, L. A. Moroz, and J. C. Hogg. 1977b. Airway mucosal permeability in the Ascark suum-sensitive rhesus monkey. J.Allergy Clin. Immunol. 60:134 - 140. Boucher, R. C., B. Ranga, P. D. Pare, S. Inoue, L. A. Moroz, and J. C. Hogg. 1978. Effect of histamine and methacholine on guinea pig tracheal permeability to HRP. J. Appl. Physiol. 45:939 - 948. Boucher, R. C., P. D. Pare, and J. C. Hogg. 1979. Rela- tionship between airway hyperractivity and hyperper- meability in ascaris sensitive monkeys. J. Allergy Clin. Immunol. 64:197 - 201. Boucher, R. C., J. Johnson, S. Inoue, W. Hulbert, and J. C. Hogg. 1980. The effect of cigarette smoke on the permeability of guinea pig airways. Lab. Invest. 43:94 - 100. Boushey, H. A., M. J. Holtzman, J. R. Sheller, and J. A. Nadel. 1980. Bronchial hyperreactivity. Am. Rev. Respir. Dis. 121:389 - 413. Bowden, D. H. 1983. Cell turnover in the lung. Am. Rev. Respir. Dis. 128~2 Pt. 2~:S46-S48. Bradley, M. O., G. Dysart, K. Fitzsimmons, P. Harbach, J. Lewin, and G. Wolf. 1982. Measurement by filter elusion of DNA single- and double-strand breaks in rat hepatopytes: Effect of nitrosamines and gamma-ir- radiation. Cancer Res. 42:2592 - 2597. Brain, J. D. 1980. Macrophage damage in relation to the pathogenesis of lung diseases. Environ. Health Perspect. 35:21 - 28. Brain, J. D., and R. Frank. 1973. Alveolar macrophage adhesion: Wash electrolytic composition and free cell yield. J. Appl. Physiol. 34:75 - 80. Brain, J. D., and G. A. Mensah. 1983. Comparative toxicology of the respiratory tract. Am. Rev. Respir. Dis. 128~2 Pt. 2~:S87-S90. Brandtzaeg, P. 1984. Immune functions of human nasal mucosa and tonsils in health and disease, pp. 28 - 95. In J. Bienenstock, Ed. Immunology of the Lung and Upper RespiratoryTract. NewYork: McGraw-Hill. Brennand, J., A. C. Chinault, D. S. Konecki, D. W. Mel REFERENCES ton, and C. T. Caskey. 1982. Cloned cDNA sequences of the lyp~anthine/guanine phosphonbosyl transferase gene from a mouse neuroblastoma cell line found to have amplified genomic sequences. Proc. Natl. Acad. Sci. USA 79:1950 - 1954. Britt, E. J., B. Cohen, H. Menkes, E. Bleecker, S. Permutt, R. Rosenthal, end P.Norman. 1980. Airways reactivity and functional deterioration in relatives of COPD patients. Chest 77:260261. Brody, A. R. 1984. Inhaled particles in human disease and animal models; Use of electron beam ~wnen~ lion. Environ. Health Perspect. 56:149 - 162. Brody, A. R., and L. H. Overby. 1989. Incorporation of tritiated thymidine by epithelial and interstitial cells in bronchiolar~veolar regions of a~bestos~pos~ rats. Am. J. Pathol. 134:133 - 140. Brody, A. R., and M. W. Roe. 1983. Deposition pattern of inorganic particles at the alveolar level in the lungs of rats and mice. Am. Rev. Respir. Dis. 128:724 729. Brody, A. R., L. H. Hill, B. Adkins, Jr., and R. W. O'Con- ner. 1981. Chrysotile asbestos inhalation in rats: Deposition pattern and reaction of alveolar epithelium end pulmonary macrophages. Am. Rev. Respir. Dis. 123:670 - 679. Brooks, S. M., M. A. Weiss, and I. L. Bernstein. 1985. Reactive airways dysfunction syndrome (RADS): Persistent asthma syndrome after high level irritant exposures. Chest 88:37~384. Buist, A. S., and B. B. Ross. 1973. Quantitative analysis of the alveolar plateau in the diagnosis of early aid obstruction. Am. Rev. Respir. Dis. 108:1078 - 1087. Butler, W. T., T. A. Waldmann, and R. D. Rossen. 1970. Changes in IgA and IgG concentrations in nasal secre- tions prior to appearance of antibody during viral respirato~yinfecdonin man. J. Immunol.105:584 591. Calleman, C. J., L. Ehrenberg, B. Jansson, S. Osterman-Golkar, D. Segerback, K. Svensson, and C. A. Wachmeister. 1978. Monitoring for risk assessment by means of allyl groups in hemoglobin in persons occupationally exposed to ethylene oxide. J. Pathol. Toxicol. 2:427 - 442. Camner, P., and K. Philipson. 1971. Intra-individual studies of tracheobronchial clearance in man using fluorocarbon resin particles tagged with i8F and 99~c, pp. 157 - 163. In W. H. Walton, Ed. Inhaled Particles III, Vol. 1. Surrey: Unwin. Camner, P., and K. Philipson. 1978. Human alveolar deposition of ~p Teflon particles. Arch. Environ. Health 33:181 - 185. Camner, P., K. Philipson, L. Friberg, B. Holma, B. Lars- son, and J. Svedberg. 1971. Human tracheobronchial clearance studies with fluorocarbon resin particles tagged with i8F. Arch. Environ. Health 22:444 - 449. Camus, A. M., A. Aitio, N. Sabadie, J. Wahrendorf, and H. Bartsch. 1984. Metabolism and urinary excretion of mutagenic metabolites of benzo~a~pyrene in C57 and DBA mice strains. Carcinogenesis 5:35 - 39. Cantin, A., and R. G. Crystal. 1985. Oxidants, antioxi- dants and the pathogenesis of emphysema. Eur. J.

REFERENCES Respir. Dis. 139(Suppl.):7 - 17. Cantin, A., R. Begin, M. Rola-Pleszczyoski, and R. Boil- eau. 1983. Heterogeneity of bronchoalveolar ravage cellularity in stage III pulmonary sarcoidosis. Chest 83:485 - 486. Cantin, A., L. North, and R. G. Crystal. 1985. Glutathi- one is present in normal alveolar epithelial lining fluid in sufficient concentration to provide antioxidant protection to lung parenchymal cells. Am. Rev. Respir. Dis. 131(4 Pt. 2) A372. (Abstract.) Carlock, L. R., T. D. Vo, C. R. DeHaven, and J. C. Murray. 1987. An anonymous genomic crone that detects a frequent RFLP adjacent to the D4S10 (G8) marker and Huntington's disease. Nucleic Acids Res. 12:377. Carp, H., and A. Janoff. 1979. In vitro suppression of serum elastase-inhibitory capacitybyreactive oxygen species generated byphagocytosingpolymorphonuclear leukocytes. J. Clin. Invest. 63:793 - 797. Center, D. M., W. Cruikshank, J. S. Berman, and D. J. Beer. 1983. Functional characteristics of histamine receptor-bearing mononuclear cells. I. Selective production of lymphocyte chemoattractant Phones with histamine used as a ligand. J. Immunol. 131:1854 - 1859. Cerny, T., D. M. Barnes, P. Hasleton, P. V. Barber, K Healy, W. Gullick and N. Thatcher. 1986. Expression of epidermal gem factor receptor (EGF-R) in human lung tumors. Br. J. Cancer 54:265 - 269. Ceuppens, J. L., L. M. Lacguet, G. Marien, M. Demedts, A. van den Eeckhout, and E. Stevens. 1984. Alveolar T-cells subsets in pulmonary sarcoidosis. Correlation with disease activity and effect of steroid treatment. Am. Rev. Respir. Dis. 129:563 - 568. Chang, L. Y., L. H. Overby, A. R. Brody, and J. D. Crapo. 1988. Progressive lung cell reactions and extracellular matrix production after a brief exposure to asbestos. Am. J. Pathol. 131:156 - 170. Chan-Yeung,M.,andS.Lam. 1986. Occupationalasth- ma. Am. Rev. Respir. Dis. 133:686 703. Chapman, H. A., Jr., O. L. Stone, and Z. Vavrin. 1984. Degradation of fibrin and elastin by human alveolar macrophages in vitro. Characterization of a plasmin~ gen activator and its role in matrix degradation. J. Clin. Invest. 73:806 - 815. Chase, M. W. 1961. The preparation and standardization of satisfactotyKveim testing antigen. Am. Rev. Respir. Dis. 84:86 - 88. Cheema, M. S., S. Groth, and C. Marriott. 1988. Binding and diffusion characteristics of i4C EDTA and ~mTc DTPA in respiratogr tract mucus glycoprotein from patientswithchronicbronchitis. Thorax43:669 - 673. Chellman, G. J., R. D. White, R. M. Norton, and J. S. Bus. 1986. Inhibition of the acute toxicity of methyl chloride in male B6C3F1 mice by glutathione depletion. Toxicol. Appl. Pharmacol. 86:93 - 104. Chen, S., V. Mahadevan, and L. Zieve. 1970a. Volatile fatty acids in the breath of patients with cirrhosis of the liver. J. Lab. Clin. Med. 75:622 - 627. 141 Chen, S., L. Zieve, and V. Mahadevan. 1970b. Mercap- tans and dimethyl sulfide in the breath of patients with cirrhosis of the liver: Effect of feeding methio- nine. J. Lab. Clin. Med. 75:628 63S. Chopra, S. K, G. V. Taplin, D. H. Simmons, and D. Elam. 1977. Measurement of mucociliary transport velocity in the intact mucosa. Chest 71:155 - 158. Chopra, S. K, G. V. Taplin, D. P. Tashkin, E. Trevor, and D. Elam. 1979. Imag ng sites of airway obstruct lion and measuring functional responses to broncho- dilator treatment in asthma. Thorax 34:493 - 500. Churg, As, and J. L. Wright. 1983. Small airways disease and mineral dust exposure. Pathol. Annul 18 (Pt. 2~:233 - 251. Cleare, M. J., E. G. Hughes, B. Jacoby, and J. Pepys. 1976. Immediate (type I) allergic responses to plati- num compounds. Clin. Allergy 6:183 - 195. Cockroft, D. W., B. A. Berscheid, and K. Y. Murdock. 1983. Unimodal distribution of bronchial responsive- ness to inhaled hi~rnine in a random human popula- tion. Chest 83:751 - 754. Coffee D. L., D. E. Gardner, R. S. Holzman, and F. J. Wolock. 1968. Influence of ozone on pulmonary cells. Arch. Environ. Health 16:633 - 636. Cohen, D. 1973. Fenomagnetic contamination in the lungs and other organs of the human body. Science 180:745 - 748. Cohen, D., S. F. Arai, and J. D. Brain. 1979. Smoking impairs long-term dust clearance from the lung. Science 204:510517. Cohen, D., T. S. Crowther, G. W. Gibbs, and M. R. Becklake. 1981. Magnetic lung measurements in relation to occupational exposure in asbestos miners and millers of Quebec. Environ. Res. 26:535 - 550. Cohen, G., and A. I. Cederbaum. 1979. Chemical evi- dence for production of hydro~cyl radicals during micro- somalelectron transfer. Science 204:6~68. Cohen, M. H. 1975. Guest editorial: Lung cancer: A status report. J. Natl. Cancer Inst. 55:505 - 511. Cole, F. S., W. J. Matthews, Jr., T. H. Rossing, D. J. Gash, N. A. Lichtenberg, and J. E. P=nin~on. 1983. Complement biosynthesis by human bronchoalveolar macrophages. Clin. Immun. Immunopathol. 27:153 - 159. Cole, P., and P. Stanley. 1983. The importance of nasal symptoms to the chest physician. Eur. J. Respir. Dis. 64(Suppl. 126~:145-148. Cole, R., C. Turton, H. Lanyon, and J. Collins. 1980. Bronchoalveolar ravage for the preparation of free lung cells: Technique and complications. Br. J. Dis. Chest 74:273 - 278. Coles, S. J., K. H. Neill, L. M. Reid, K. F. Austen, Y. Nil, E. J. Corey, and R. A. Lewis. 1983. Effects of leukotrienes C4 and D4 on ~ycoprotein and lysoyme secretion by human bronchial mucosa Prostaglandins 25:155 - 170. Colten, H. R., and L. P. Einstein. 1976. Complement metabolism: Cellular and immoral regulation. Tram plant Rev. 32:3 - 11. s

142 Colten, H. R., C. A. Alper, and F. S. Rosen. 1981. Genetics and biosynthesis of complement proteins. N. Engl. J. Med. 304:653 - 656. Conkle, J. P., B. J. Camp, and B. E. Welch. 1975. Trace composition of human respiratory gas. Arch. Environ. Health 30:290295. Connell, J. T. 1979. A novel method to assess antihis- tamine and decongestant efficacy. Ann. Allergy 42:278 - 285. Conner, M. W., A. E. Rogers, and M. O. Amdur. 1982. Response of guinea pig respiratory tract to inhalation of submicron zinc oxide particles generated in the presence of sulfur dioxide end wafer vapor. Toxicol. Appl. Pharmacol. 66:434 - 442. Conner, M. W., I. Chaudhuri, A. E. Rogers, and M. O. Amdur. 1985. Kinetics of respiratory tract absorption and plasma clearance of horseradish peroxidase in guinea pigs. Fundam. Appl. Topical. 5:99 - 104. Cormier, Y., J. Belanger, J. Beaudoin, M. Laviolette, R. Beaudoin, end d. Herbert. 1984. Abnormalbron- choalveolar ravage in asymptomatic dairy farmers: Study of lymphocytes. Am. Rev. Respir. Dis. 130:1046 - 1049. Cormier, Y., J. Belanger, and M. Laviolette. 1986. Persis- tent bronchoalveolar lymphocytosis in asymptoma- tic farmers. Am. Rev. Respir. Dis. 133:843 - 847. Cormier, Y., J. Belanger, and M. LavioleKe. 1987. Prom noetic significance of bronchoalveolar lymphocyto- sis in farmer's lung. Am. Rev. Respir. Dis. 135:692 - 695. Cosio, M., H. Ghezo, J. C. Hogg, R. Corbin, M. Love- land, J. Dosman, and P. T. Macklem. 1978. The relations between structural changes in small airways and pulmonary-function tests. N. Engl. J. Med. 298:1277 - 1281. Costabel, U., K. J. Bross, J. Marxen, and H. Matthys. 1984. T-lymphocytosis in bronchoalveolar ravage fluid of hypersensitivity pneumonitis. Changes in profile of T-cell subsets during the course of disease. Chest 85:514 - 518. Cramer, W. O., and W. C. Miller. 1977. A computerized approach to closing volume determination. Ann. Allergy 38:22 - 26. Crapo, R. O., and A. H. Morris. 1981. Standardized single breath normal values for carbon monoxide diffusing capacity. Am. Rev. Respir. Dis. 123:1854189. Craven, N., G. Sidwall, P. West, D. S. McCarthy, and R. M. Cherniack. 1976. Computer analysis of the single-breath nitrogen washout curve. Am. Rev. Respir. Dis. 113:445 - 449. Cresia, D. A., P. Netteshe~m, and A. S. Hammons. 1973. Impairment of deep lung clearance by influenza virus infection. Arch. Environ. Health 26:197 - 201. Creticos, P. S., S. P. Peters, N. F. Adkinson, Jr., R. M. Naclerio, E. C. Hayes, P. S. Norman, and L. M. Lich- tenstein. 1984. Peptide leukotriene release after antigen challenge in patients sensitive to ragweed. N. Engl. J. Med. 310:1626 - 1630. Crimi, D., A. Scordamaglia, P. Crimi, S. Zupo, and S. REFERENCES Barocci. 1983. Total and specific IgE in serum, bronchial ravage and bronchoalveoalar ravage of asth- matic patients. Allergy 38:553 - 559. Crystal, R. G., W. C. Roberts, G. W. Hunninghake, J. E. Gadek, J. D. Fulmer, and B. R. Line. 1981. Pul- monary sarcoidosis: A disease characterized and perpetuated by activated lung T-lymphocytes. Ann. Intern. Med. 94:73 - 94. Cuddihy, R. G., B. B. Boecker, and W. C. Griffith. 1979. Modelling the deposition and clearance of inhaled radionuclides, pp. 77 - 89. In International Atomic EnergyAgency. Biological Implications of Radionu- clides Released from Nuclear Industries: Proceedings of the International Symposium on Biological Implica- tions of Radionuclides Released from Nuclear In- dustries, Vienna, 2~30 March 1979. Vol. II. Vienna: International Atomic Energy Agency. Cumming, G., and S. J. Semple. 1980. Disorders of the Respiratory System, 2nd ed. Oxford: Blackwell Scientific Publications. 616 pp. Cutillo, A. G., A. H. Morris, D. D. Blatter, T. A. Case, D. C. Ailion, C. H. Durney, and S. A. Johnson. 1984. Determination of lung water content and distribution by nuclear magnetic resonance. J. Appl. Physiol. 57:583 - 588. Daly, A. R., J. M. Benson, R. L. Hanson, and S. J. Roth- enberg. 1984. The fractionation of environmental samples according to Salary by vacuum l~yogenic distillation. Am. Ind. Hyg. Assoc. J. 45:193 - 198. Dahl, A. R., L. S. Birnbaum, J. A. Bond, P. G. Gervasi, and R. F. Henderson. 1987. The fate of isoprene inhaled by rats: Comparison to butadiene. Toxicol. Appl. Pharmacol. 89:237 - 248. Dally, M. B., J. V. Hunter, E. G. Hughes, M. Stewart, end A. J. Newman Taylor. 1980. Hypersensitivity to platinum salts: A population study. Am. Rev. Respir. Dis. 121(Suppl):230. (Abstract.) Daniele, R. P. 1980. Immune defenses of the lung, pp. 624~632. In A. P. Fishman, Ed. Pulmonary Diseases and Disorders, Vol. 1. New York: McGraw-Hill. Daniele, R. P., M. D. Altose, and D. T. Rowlands, Jr. 1975. Immunocompetent cells from the lower respira- tory tract of normal human lungs. J. Clin. Invest. 56:986 - 995. Daniele, R. P., C. H. Beacham, and D. J. Gorenberg. 1977a. The bronchoalveolar lymphocyte: Studies on the life history and lymphocyte traffic from blood to the lung. Cell. Immunol. 31:48 - 54. Daniele, R. P., J. H. Dauber, M. D. Altose, D. T. Row- lands, Jr., and D. J. Gorenberg. 1977b. Lymphocyte studies in asymptomatic cigarette smokers. A com- parison between lung and peripheral blood. Am. Rev. Respir. Dis. 116:997 - 1005. Daniele, R. P., J. H. Dauber, and M. D. Rossman. 1980. Immunologic abnormalitiesin sarcoidosis. Ann. Intern. Med. 92:406 416. Daniele, R. P., J. A. Elias, P. E. Epstein, and M. D. Rossman. 1985. Bronchoalveolar ravage: Role in the pathogenesis, diagnosis, and management of inter

REFERENCES stitial lung disease. Ann. Intern. Med. 102:93 - 108. Dauber, J. H., M. D. Rossman, and R. P. Daniele. 1979. Bronchoalveolar cell populations in acute sarcoidos~s: Observations in smoking and nonsmoking patients. J. Lab. Clin. Med. 94:862 - 871. Davis, W. B., S. I. Rennard, P. B. Bitterman, and R. G. Crystal. 1983. Pulmonary oxygen toxicity: Early reversible changes in human alveolar structures induced by hyperopia. N. Engl. J. Med. 309:878 - 883. Davis, W. B., G. A. Fells, X. H. Sun, J. E. Gadek, A. Venet, and R. G. Crystal. 1984. Eos~nophil-mediated injury to lung parenchymal cells and interstitial matrix: A possible role for eosinophils in chronic inflammatory disorders of the lower respiratory tract. J. Clin. Invest. 74:269 - 278. Dawson, A. 1982. Elastic recoil and compliance, pp. 193 - 204. In J. L. Clausen, Ed. Pulmonary Function Testing Guidelines and Controversies: Equipment, Methods, end NormalValues. New York: Academic Press. De Meo, M. P., G. Dumenil, A. H. Botta, M. Laget, V. Zabaloueff, end A. Mathias. 1987. Urine mutageni- city of steelworkers exposed to coke oven emissions. Carcinogenesis 8:363 - 367. De Monchy, J. G. R., H. F. Kauffman, P. Venge, G. H. Koeter, H. M. Jansen, H. J. Sluiter, and K. De Vries. 1985. Bronchoalveolar eosinophilia during allergen-in- duced late asthmatic reactions. Am. Rev. Respir. Dis. 131:373 - 376. Dempsey, R. A., C. A. Dinarello, J. W. Mier, L. J. Rosen- wasser, M. Allegretta, T. E. Brown, and D. R. Parkin- son. 1982. The differential effects of human leukocyte pyrogen/lymphocyte-activating factor, T cell growth factor, and interferon on human natural killer activity. J. Immunol. 129:2504 - 2510. DeNicola, D. B., A. H. Rebar, and R. F. Henderson. 1981. Early damage indicators in the lung. V. Bio- chemical and cytological response to NO2 inhalation. Toxicol. Appl. Pharmacol. 60:301 - 312. Deodhar, S. D., B. Barna, and H. S. Van Ordstrand. 1973. A study of the immunologic aspects of chronic berylliosis. Chest 63:309 - 313. De Vuyst, P. P. Dumortier, E. Moulin, N. Yourassowdy, and J. C. Yernault. 1987. Diagnostic value of asbestos bodies in Bronchoalveolar ravage fluid. Am. Rev. Respir. Dis. 136:1219 - 1224. Diaz, P., F. R. Galleguillos, M. C. Gonzalez, C. F. A. Pantin, and A. B. Kay. 1984. Bronchoalveolar ravage in asthma: The effect of disodium cromoglycate (cromolyn) on leukocyte counts, immunoglobulins, and complement. J. Allergy Clin. Immunol. 74:41 - 48. Dinarello, C. A. 1984. Interleukin-1 and the catho~enesis of the acute-phase response. 311:1413 - 1418. - - - r ~ N. Engl. J. Med. Dohn, M. N., and R. P. Baughman. 1985. Effect of changing instilledvolume for Bronchoalveolar ravage in patients with interstitial lung disease. Am. Rev. Respir. Dis. 132:39~392. Dolovich, M. B. 1985. Technical factors influencing 143 response to challenge aerosols, p. 9. In F. E. Har- greave and A. J. Woolcock, Eds. Airway Respon- s*eness: Measurement and Interpretation. Missis- sauga: Astra Pharmaceuticals Canada Ltd. Dolovich, M. B., J. Sanchis, C. Rossman, and M. T. Newhouse. 1976. Aerosolpenetrance: A sensitive index of peripheral airways obstruction. J. Appl. Physiol. 40:468 - 471. Dorin, J. R., M. Novak, R. E. Hill, D. J. Brock, D. S. Secher, and V. van Heyningen. 1987. A clue to the basic defect in cystic fibrosis from cloning the CF antigen gene. Nature 326~6113~:614 - 617. Dozy, A. M., E. N. Forman, D. N. Abuelo, G. Barsel-Bow- ers, M. J. Mahoney, B. G. Forget, and Y. W. Kan. 1979. Prenatal diagnosis of homozygous alpha-thalasse mia. J. Am. Med. Assoc. 241:161~1612. Drazen, J. M., K. F. Austen, R. A. Lewis, D. A. Clark, G. Goto, A. Marfat, and E. J. Corey. 1980. Compara- tive airway end vascular activities of leukotrienesC-1 and D in viva and in vitro. Proc. Natl. Acad. Sci. USA 77:4354 - 4358. Dunn. B. P. 1983. Wide-rance linear dose-response _ curve for DNA binding of orally administered ben- zoia~pyrene in mice. Cancer Res. 43:2654 - 2658. Dusser, D. J., M. A. Collignon, G. Stanislas-Leguern, L. G. Barritault, J. Chretien, and G. J. Huchon. 1986a. Respiratory clearance of 99mT~DTPA and pulmonary involvement in sarcoidosis. Am. Rev. Respir. Dis. 134:493 - 497. Dusser, D. J., B. D. Minty, M. A. Collignon, D. Hinge, L. G. Barritault, and G. J. Huchon. 1986b. Regional respiratory clearance of aerosolized 99mTc-DTPA: Posture and smoking effects. J. Appl. Physiol. 60:2000 2006. Eden, E., and G. M. Turino. 1986. Interleukin-1 secre- lion by human alveolar macrophages stimulated with endoto~n is augmented by recombinant immune (gamma) interferon. Am. Rev. Respir. Dis. 133:455-460. Effros, R. M. 1985. Lung water measurements with the mean transit time approach. J. Appl. Physiol. 59:673 - 683. Egan, E. A. 1980. Response of alveolar epithelial solute permeability to changes in lung inflation. J. Appl. Physiol. 49:1032 - 1036. Eggleston, P. A., J. O. Hendley, and J. M. Gwaltney, Jr. 1984. Mediators of immediate hypersensitivity in nasal secretions during natural colds and rhinovirus infection. Acta Otola~yngol. 413(Suppl.~:25 - 35. Ehrlich, R., J. C. Findlay, J. D. Fenters, and D. E. Gard- ner. 1977. Health effects of short-term inhalation of nitrogen dioxide and ozone mixtures. Environ. Res. 14:223 - 231. Eisenberg, P. R., J. R. Hansbrough, D. Anderson, and D. P. Schuster. 1987. A prospective study of lung water measurements during patient management in an intensive care unit. Am. Rev. Respir. Dis. 136:662-668. El-Dorry, H. A., C. B. Pickett, J. S. MacGregor, and

144 R. L. Soffer. 1982. Tissue-speci6~c expression of mRNAs for dipeptidyl carboxypeptidase isozymes. Proc. Natl. Acad. Sci. USA 79:4295 - 4297. Elias, J., M. D. Rossman, R B. Zurier, and R. P. Daniele. 1985a. Human alveolar macrophage inhibition of lung fibroblast growth. A prostaglandin-dependent process. Am. Rev. Respir. Dis. 131:94 - 99. Elias, J. A., A. D. Schreiber, K. Gustilo, P. Chien, M. D. Rossman, P. J. Lammie, and R. P. Daniele. 1985b. Differential interleukin 1 elaboration byunfractionated and density fractionated human alveolar macrophages and blood monocytes: Relationship to cell maturity. J. Immunol. 135:3198 - 3204. Elliott, F. J., and L. Reid. 1965. Some new facts about the pulmonary artery and its branching pattern. Clin. Radial. 16:193. Emmett, P. C., R. G. Love, W. J. Hannan, A. M. Millar, and C. A. Soutar. 1984. The relationship between the pulmonary distribution of inhaled fine aerosols and tests of airwayfunction. Bull. Eur. Physiopathol. Respir. 20:325 - 332. Engel, L. A. 1983. Gas mixing within the acinus of the lung. J. Appl. Physiol. 54:609 - 618. Engel, L. A., and P. T. Macklem. 1977. Gas mixing and distribution in the lung, pp.37 - 82. In J. G. Wid- dicombe,Ed. Respiratory Physiology II. International Review ofPhysiolo~r, VoL 14. Baltimore: University Park Press. Engel, L. A., A. Grassino, and N. R. Anthonisen. 1975. Demonstration of ainvay closure in man. J. Appl. Physiol. 38:1117 - 1125. Enterline, P. E., V. L. Henderson, and G. M. Marsh. 1987. Exposure to arsenic and respiratory cancer: A reanalysis. Am. J. Epidemiol. 125:929 - 938. Epstein, P. E., J. H. Dauber, M. D. Rossman, and R. P. Daniele. 1982. Bronchoalveolar ravage in a patient with chronic be~ylliosis: Evidence for hypersensitivity pneumonitis. Ann. Intern. Med. 97:213 - 216. Ernst, P., D. Thomas, and M. R B~ake. 1986. Respi- ratory survey of North American Indian children living in pro~mity to an aluminum smelter. Am. Rev. Respir. Dis. 133:307 - 312. Eschenbacher, W. L., and T. R. Gravelyn. 1987. A technique for isolated airway segment ravage. Chest 92:105 - 109. Ettensohn, D. B., P. A. Lalor, and N. J. Roberts, Jr. 1986. Human alveolar macrophage regulation of l~rmphocyte proliferation. Am. Rev. Respir. Dis. 133:1091 - 1096. Evans, M. J. 1982. Cell death and cell renewal in small airways and alveoli, pp.189 - 218. In H. Witschi, and P. Nettesheim, Eds. Mechanisms in Respiratory Toxicology. Boca Raton, Fla.: CRC Press. Fahey, P. J., M. J. Utell, R. J. Mayewski, J. D. Wandtke, and R. W. Hyde. 1982. Early diagnosis ofbleomycin pulmonary toxicity using bronchoalveolar ravage in dogs. Am. Rev. Respir. Dis. 126:126 130. Faith, R. E., M. I. Luster, and J. G. Vos. 1980. Effects on immunocompetence by chemicals of en~rironmental REFERENCES concern, pp. 173 - 212. In E. Hodgson, J. R. Bend, and R. M. Philpot, Eds. Reviews in Biochemical Toxicology, Vol. 2. New York: Elsevier. Farr, B., S. F. Hackett, B. Winther, and J. O. Hendley. 1984. A method for measuring polymorphonuclear leukocyte concentrations in nasal mucus. Acta Oto- laryngol. 413(Suppl.):15 - 18. Fauci, A. S., A. hI. Macher, D. L. Longo, H. C. Lane, A. H. Rook, H. Masur, and E. P. Gelmann. 1984. NIH conference. Acquired immunodeficiency syn- drome: Epidemiologic, clinical, immunologic and therapeutic considerations. Ann. Intern. Med. 100:92 - 106. Feinberg, A. P., and B. Vogelstein. 1983. Hypomethyla- tion distinguishes genes of some human cancers from their normal counterparts. Nature 301(5895):89 - 92. Felarca, A. B., and F. C. L~veLL 1971. The accumulation of eosinophils and basophils at skin sites as related to intensity of skin reactivity and symptoms of atopic disease. J. Allergy Clin. Immunol. 48:125 - 133. Felicetti, S. A., R. K. Wolff, and B. A. Muggenburg. 1981. Comparison of tracheal mucous transport in rats, guinea pigs, rabbits, and dogs. J. Appl. Physiol. 51:1612 - 1617. Fels, A. O. S., and Z. A. Cohn. 1986. The alveolar macrophage. J. Appl. Physiol. 60:353 - 369. Ferns, B. G. 1978. Epidemiology Standardization Project (American ThoracicSoc~ety). Am. Rev. Respir. Dis. 118(6 Pt. 2):1 - 120. Ferro, T. J., J. A. Kern, J. A. Elias, M. Kamoun, R. P. Daniele, and M. D. Rossman. 1987. Alveolar macro- phages, blood monocytes, and density-fractioned alveolar macrophages differ in their ability to promote lymphocyte proliferation to mitogen and antigen. Am. Rev. Respir. Dis. 135:682 - 687. Finch, G. L., G. L. Fisher, T. L. Ha~res, and D. W. Golde. 1982. Surface morphology and functional studies of human alveolar maaophages from cigarette smokers and nonsmokers. J. Reticuloendothel. Soc. 32:1 - 23. Finley, T. N., E. W. Swenson, W. S. Curran, G. L. Huber, end A. J. Ladman. 1967. Bronchopulmonary ravage in normal subjects and patients with obstructive lung disease. Ann. Intern. Med. 66:651 - 658. Fiserova-Bergerova, V., Ed. 1983. Modeling of Inhalation Exposure to Vapors: Uptake, Distribution and Elimi- nation. Vol. I and II. Boca Raton, Fla.: CRC Press. Fiserova-Bergerova, V., and D. A. Holaday. 1979. U~ take and clearance of inhalation anesthetics in man. Drug. Metab. Dispos. 9:43 - 60. Fiserova-B=geova, V., J. Vlach, and J. C. Cassady. 1980. Predictable "individual differences" in uptake and exaction of gases and lipid soluble vapour simulation study. Br. J. Indust. Med' 37:42 - 49. Fishman, A. P., Ed. 1980. Pulmonary Diseases and Disorders. New York: McGraw-Hill. 2vols. Fletcher, C. M., R. Peto, C. M. Tinker, and F. E. Speizer. 1976. The Natural History of Chronic Bronchitis and Emphysema: An Eight-Year Study of Working Men

REFERENCES . in London. New York: Oxford University Press. 272 pp. Forkert, L., S. Dhingra, and N. R. Anthonisen. 1979. Airway closure and closingvolume. J. Appl. Physiol. 46:24 - 30. Foster, W. M., E. G. Langenback, D. Bohning, and E. H. Bergofsky. 1978. Quantitation of mucus clearance in peripheral lung and comparison with tracheal and broncial mucus transport velocities in man: Adrener- gics return depressed clearance and transport velocities in asthmatics to normal. Am. Rev. Respir. Dis. 117(Suppl.~:337. (Abstract.) Foster, W. M., E. G. Langenback, and E. H. Bergofsky. 1982. Lung mucociliary function in man: Interdepen- dence of bronchial and tracheal mucus transport velocities with lung clearance in bronchial asthma and healthy subjects. Ann. Occup. Hyg.26:227 - 244. Foster, W. M., E. G. Langenback, and E. H. Bergofsky. 1985. Disassociation in the mucociliary function of central and peripheral airways of asymptomatic smok- ers. Am. Rev. Respir. Dis. 132:633 - 639. Fowler, W. S. 1949. Lung function studies. m. Uneven pulmonary ventilation in normal subjects and in pa- tients with pulmonary disease. J. Appl. Physiol. 2:283 - 299. Frampton, M. W., A. M. Smeglin, N. J. Roberts, Jr., J. N. Finkelstein, P. E. Morrow, and M. J. Utell. 1987. Intermittent peak versus continuous NO2 ex- posure: Effects on human alveolar macrophages. Am. Rev. Respir. Dis. 135:A58. (Abstract.) Freedman, A. P., and S. E. Robinson. 1981. Evaluation of magnetopneumography for assessing thoracic ac- cumulation of welding fume particulate and lung dust clearance, pp. 489 - 496. In S. N. Erne, H. D. Hahlbohm and H. Lubbig, Eds. Biomagnetism. Pro- ceedings Third International Workshop on Biomag: netism, Berlin (West), May 1980. Berlin: de Gruyter. Freedman, A. P., S. E. Robinson, and R. J. Johnston. 1980. N o n - i n v a s i v e m a g n e t o p n e u m o g r a p h i c e s t i m a t i o n of lung dust loads and distnbution in bituminous coal workers. J. Occup. Med. 22:613 - 618. Freedman, A. P., S. E. Robinson, and F. H. Y. Green. 1982. Magnetopneumography as a tool for the study of dust retention in the lungs. Ann. Occup. Hyg. 26:319 - 335. Freeman, B. A., and J. D. Crapo. 1981. Hyperoxia increases oxygen radical production in rat lungs and lung mitochondria. J. Biol. Chem.256: 10986 - 10992. Freeman, B. A., and J. D. Crapo. 1982. Free radicals and tissue inju~y. Lab Invest. 47:412 - 426. Friedman, M., F. D. Stott, D. O. Poole, R. Dougherty, G. A. Chapman, H. Watson, and M. A. Sackner. 1977. A new roentenographic method for estimating mucous velocity in anways. Am. Rev. Respir. Dis. 115:67 - 72. Friend, S. H., R. Bernards, S. Rogelj, R. A. Weinberg, J. M. Rapaport, D. M. Albert, and T. P. D~a. 1986. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. 145 Nature 323~6089~:643 - 646. Gadek, J. E., G. A. Fells, D. G. Wright, and R. G. Crystal. 1980. Human neutrophil elastase functions as a type III collagen "collagenase." Biochem. Biophys. Res. Commun. 95:1815 - 1822. Gadek, J. E., G. A. Fells, R. L. Zimmerman, S. I. Ren- nard, and R. G. Crystal. 1981. Antielastases of the human alveolar structures. Implications for the protease-antiprotease theory of emphysema. J. Clin. Invest. 68:889 - 898. Galdston, M., V. Levytska, V., M. S. Schwartz, and B. Magnusson. 1984. Ceruloplasmin: Increased serum concentration and impa*ed antioxidant activity in cigarette smokers, and ability to prevent suppression of elastase inhibitory capacity of alpha 1-proteinase inhibitor. Am. Rev. Respir. Dis. 129:258 - 263. Gamou, S., J. Hunts, H. Hangai, S. Hirohashi, Y. Shimo- sato, I. Pastan, and N. Shimizu. 1987. Molecular evidence for the lack of epidermal growth factor receptor gene expression in small cell lung carcinoma cells. Cancer Res. 47:2668 - 2673. Gamsu, G., R. M. Weintraub, and J. A. Nadel. 1973. Clearance of tantalum from ainvays of different cal~ber in man evaluated by a roentgenographic method. Am. Rev. Respir. Dis. 107:214 - 224. Ganey, P. E., and R. A. Roth. 1987. Elevated serum copper concentration in monocrotaline pyrrole treated rats with pulmonary hypertension. Biochem. Phar- macol. 36:3535 - 3537. Garcia, J. G. N., R. G. Wolven, P. L. Garcia, and B. A. Keogh. 1986. Assessment of interlobar variation of bronchoalveolar ravage cellular differentials in interstitial lung diseases. Am. Rev. Respir. Dis. 133:444 - 449. Gearhart, J. M., and R. B. Schlesinger. 1987. A mor- phometric analysis of rabbit airways after repeated exposure to sulfuric acid aerosol. Toxicologist 7:193. Gearhart, J. M., and R. B. Schlesinger. 1988. Response of the tracheobronchial mucociliary clearance system to repeated irritant exposure: Effect of sulfuric acid mist on function and structure. Exp. Lung Res. 14:587 - 606. Gebhart, J., J. Heyder, and W. Stahlhofen. 1981. Use of aerosols to estimate ~rrona~y air-ppace dimensions J. Appl. Physiol. 51:465 - 476. Geggel, R. L., A. C. A. Ca~valho, L. W. Hoyer, and L. M. Reid. 1987. Von Willebrand factor abnormalities in primary pulmona~y hypertension. Am. Rev. Respir. Dis. 135:294 - 299. Gelb, A. F., and N. Zamel. 1973. Simplif~ed diagnosis of small airway obstruction. N. Engl. J. Med. 288:395 - 398. Gerberick, G. H., H. A. Jaffe, J. B. Willoughby, and W. F. Willoughby. 1986. Relationships between pul- monary inflammation, plasma transudation, and o~gen metabolite secretion by alveolar macrophages. J. Immunol. 137:114 - 121. Gillis, C. N., and B. R. Pitt. 1982. The fate of circulating amines within the pulmona~y circulation. Annul Rev.

146 Physiol. 44:269 - 281. Ginns, L. C., P. D. Goldenheim, R. C. Burton, R. B. Colvin, L. G. Miller, G. Goldstein, C. Hurwitz, and H. Kazemi. 1982. T-lymphocyte subsets in peripheral blood and lung ravage in idiopathic pulmonary fibrosis and sarcoidosis: Analysis by monoclonal antibodies and flow cytometry. Clin. Immunol. Immunopathol. 25:11 - 20. Gleich, G. J., E. Frigas, D. A. Loegering, D. L. Wasson, and D. Steinmuller. 1979. Cytotoxic properties of the eosinophil major basic protein. J. Immunol. 123:2925 - 2927. Godard, P., J. Clot, O. Jonquet, J. Bousquet, and F. B. Michel. 1981. Lymphocytesubpopulationsinbroncho- alveolar ravages of patients with sarcoidosis and hyper- sensitivity pneumonitis. Chest 80:447 - 452. Gold,P.M. 1982. Single breath nitrogen test: Closing volume and distribution of ventilation, pp. 105 - 114. In J. L. Clausen, Ed. Pulmonary Function Testing Guidelines and Controversies: Equipment, Methods, and Normal Values. New York: Academic Press. Golden, J. A., J. A. Nadel, and H. A. Boushey. 1978. Bronchial hyperirritability in healthy subjects after ~posure to ozone. Ant Rev. Respir. D~ 118 287 - 294. Gongora, G., M. Roy, R. Gongora, P. Drutel, J. P. Gail- lard, and H. Jammet. 1981. Bronchopulmona~y clearance of radioactive labelled particles among 90 normal and pathological subjects. In H. Hauck, Ed. Pro~gs of International Symposium on Deposition and Clearance of Aerosols, Bad Gleichenberg,Austria Vienna: Arbeitsgemeinschaft fur Aerosols in der Medizine. Gonzalez, F. J., A. K. Jaiswal, and D. W. Nebert. 1986. P450 genes: Evolution, regulation and relationship to human cancer and pharmacogenetics. Cold Spring Harbor Symp. Quant. Biol. 51(Pt. 2~:879 - 890. Goodman, R. M., B. M. Yergin, J. F. Landa, M. H. Golinvaux, and M. A. Sackner. 1978. Relationship of smoking history and pulmonary function tests to tracheal mucus velocityin nonsmokers, young smokers, ax-smokers and patients with chronic bronchitis. Am. Rev. Respir. Dis. 117:205 - 214. Gordon, T., J. E. Thompson, and D. Sheppard. 1988. Arachidonic acid metabolites do not mediate toluene diisocyanate-induced airway hyperresponsiveness in guinea pigs. Prostaglandins 35:699 - 706. Gorin, A. B., W. J. Weidner, R. H. Demling, and N. C. Staub. 1978. Noninvasive measurement of pul- monary transvascular protein flux in sheep. J. Appl. Physiol. 45:225 - 233. Gosmset, P., A. B. TonneL M. Joseph, L. Prin, A. Mallart, J. Charon, and A. Capron. 1984. Secretion of a chemotactic factor for neutrophils and eosinophils by alveolar macrophages from asthmatic patients. J. Allergy Clin. Immunol. 74:827 - 834. Graham, D., F. W. Henderson, and D. House. 1988. Neutrophil influx measured in nasal ravages of humans exposed to ozone. Arch. Environ. Health.43:228 233. Green, L. C., P. L. Skipper, R. J. Turesly, M. S. BIyant, REFERENCES and S. R. Tannenbaum. 1984. In vivo dosimetry of 4aminobiphenyl in rats via a cysteine adduct in hemo- globin. Cancer Res. 44:4254 - 4259. Greening, A. P., and D. B. Lowrie. 1983. Extracellular release of lydro~ pero~de l~y human alveolar macro phages. The relationship to cigarette smoking and lower respiratory tract infections. Clir~ Sci 65:661 664. Griffin, M., J. W. Weiss, A. G. Leitch, E. R. McFadden, Jr., E. J. Corey, K F. Austen, and J. M. Drazen. 1983. Effects of leukotriene D on the airways in asthma. N. Engl. J. Med. 308:436 - 439. Griffith, W. C., R. C. Cuddihy, B. B. Boecker, R. A. Guilmette, M. A. Medinsly, and J. A. Mewhinney. 1983. Comparison of solubility of aerosols in lungs of Laboratory ar~naK Health Phy~ 45:233. (Abstract.) Groopman, J. D., P. R. Donahue, J. Q. Zhu, J. S. Chen, and G. N. Wogan. 1985. Aflatoxin metabolism in humans: Detection of metabolites and nucleic acid adductS-in urine by affinity chromatography. Proc. Natl. Acad. Sci. USA 82:6492 - 6496. Groopman, J. D., B. D. Roebuck, and T. W. Kensler. 1987. Application of monoclonal antibodies and cfieta~y antioxidant-based animal models to define human exposure to aBatoxin B~. Prog. Exp. Tumor Res. 31:52 - 62. Gross, M. L., J. O. Lay, Jr., P. A. Lyon, D. Lippstreu, N. Kansas, R. L. Harless, S. E. Taylor, and A. E. Dupay, Jr. 1984. 2,3,7,8,-Tetrachlorod~benzo-~di~n levels in adipose tisme of Vietnam veterans. Em~ron. Res. 33:261 - 268. Grover, M., R A. Slutiky, C. B. E~ and R Sha~ai 1983. ~avasallarlungwaterinpatientswithconges- tive heart failure. Radiology 147:659 - 662. Gupta,R.C. 1987. 32p-Postlabeling assay to measure carcinogen-DNA adducts. Prog. Exp. Tumor Res. 31:21 - 32. Hadfield, E. H., and R. G. MacBeth. 1971. Adenocar- cinoma of ethmoids in furniture workers. Ann. Otol. Rhinol. I=gngol. 80:699 - 703. Halpern, M., S. J. Williamson, D. M. Spektor, R. B. Schlesinger, and M. Lippmann. 1981. Remanent magnetic fields for measuring particle retention and distribution in the lung. Exp. Lung Res. 2:27 - 35. Hance, A. J., S. Douches, R J. Winchester, V. J. Ferrans, and R G. CrystaL 1985. Charactenzation of mononu- clear phagocyte subpopulations in the human lung by using monoclonal antibodies: Changes in alveolar macrophage phenotype associated with pulmonaIy sarcoidosis. J. Immunol. 134:284 292. Hanifin, J. M., W. L. Epstein, and M. J. Cline. 1970. In vitro studies of granulomatous hypersensitivity to be~yllium. J. Invest. Dermatol. 55:284 288. Hankinson, J. L., E. D. Palmes, and N. L. Lapp. 1979. Pulmona~y airspace size in coal miners. Am. Rev. Respir. Dis. 119:391 - 397. Hansen, J. E. 1982. Exercise testing, pp. 259 - 279. In J. L. Clausen, Ed PulmonatyFunctionTe~fingGuide- lines and Controversies: Equipment, Methods, and Normal Values. New York: Academic Press.

REFERENCES Hargreave, F. E., and A. J. Woolcock, Eds. 1985. Airway Responsiveness: Measurement and Interpretation. Mississauga: Astra Pha~.~aceuticals Canada. Hargreave, F. E., J. Dolovich, and L. P. Boulet. 1983. Inhalation provocation tests. Semin. Respir. Med. 4:224 - 236. Hargreave, F. E., P. M. O'Byrne, and E. H. Ramsdale. 1985. Mediators, airway responsiveness, and asthma. J. Allergy Clin. Immunol. 76~2 Pt. 2~:272 - 276. Harper, E. 1980. Collageneases. Annul Rev. Biochem. 49:1063 - 1078. Harris, C. C., A. Weston, J. C. Willey, G. E. Trivers, and D. L. Mann. 1987. Biochemical and molecular epidemiology of human cancer: Indicators of car- c~nogen exposure, DNA damage, and genetic predispo sition. Environ. Health Perspect. 75:109 - 119. Harris, P., and D. Heath. 1986. The Human Pulmonary Circulation: Its Form and Function in Health and Disease, 3rd ed. New York: ChurchillLivingstone. 702 pp. Hatch, G. E., H. Koren, R. Slade, K. Crissman, and J. Norwood. 1987. Effect of acute ozone (O3) exposure on human and rat ravage fluid biochemistry. Toxicolo- gist 7:10. Hatton, D. V., C. S. Leach, A. E. Nicogossian, and N. di Ferrante. 1977. Collagen breakdown and nitrogen dioxide inhalation. Arch. Environ. Health32:33 - 36. Haugen, A., G. Becher, C. Benestad, K. Vahakangas, G. E. Trivers, M. J. Newman, and C. C. Harris. 1986. Determination of polycyclic aromatic hydrocar- bons in the urine, benzo~a~pyrene diol epoxide-DNA adducts in lymphocyte DNA, and antibodies to the adducts in sera from coke oven workers exposed to measured amounts of polycyclic aromatic hydrocarbons in the work atmosphere. Cancer Res.46:4178 - 4183. Havill, A. M., and M. H. Gee. 1984. Role of interstitium in clearance of alveolar fluid in normal and injured lungs. J. Appl. Physiol. 57:1 - 6. Heath, D., and J. E. Edwards. 1958. The pathology of hypertensive pulmonary vascular disease: A descrip- tion of six grades of structural changes in the pul- monary arteries with special reference to cogenital cardiac septal defects. Circulation 18:533 - 547. Hedlund, L. W., P. Vock, E. L. Effman, M. M. Lischko, and C. E. Putman. 1984. Hydrostatic pulmonary edema: An analysis of lung density changes by com- puted-tomography. Invest. Radiol. 19:254 - 262. Hedlund, L. W., P. Vock, E. L. Effman, and C. E. Put- man. 1985. Morphology of oleic acid-induced lung injury. Invest. Radiol. 20:2 - 8. Heinrich, U., H. Muhle, S. Takenaka, H. Ernst, R. Fuhst, U. Mohr, F. Pott, and W. Stober. 1986. Chronic effects on the respiratory tract of hamsters, mice and rats after longterm inhalation of high concentrations of filtered and unfiltered diesel engine emissions. J. Appl. Toxicol. 6:393 - 395. Henderson, R. F. 1984. Use of bronchoalveolar ravage to detect lung damage. Environ. Health Perspect. 56:115 - 129. 147 Henderson, R. F. 1988a. Use of bronchoalveolar ravage to detect lung damage, pp.239 - 268. In D. E. Gardner, J. D. Crapo, and E. J. Massaro, Eds. Toxicology of the Lung. Target Organ Toxicology Series. New York: Raven Press. Henderson, R. F. 1988b. Bronchoalveolarlavage: A tool for assessing the health status of the lung. In R O. McClelland and R F. Hende~ Eds Conc~pts in Inhalation Toxicology. Washington, D.C.: Hemi- sphere. Henderson, R. F., A. H. Rebar, J. A. Pickrell, and G. J. Newton. 1979a. Early damage indicators in the lung. III. Biochemical and cytological response of the lung to inhaled metal salts. Toxicol. Appl. Phar- macol. 50:123 - 136. Henderson, R. F., A. H. Rebar, and D. B. DeNicola. 1979b. Early damage indicators in the lungs. IV. Biochemical and cytological response of the lung to inhaled metal salts. Toxicol. Appl. Pharmacol. 51:129 - 135. Henderson, R. F., J. M. Benson, F. F. Hahn, C. H. Hobbs, R. K. Jones, J. L. Mauderly, R. O. McClellan, and J. A. Pickrell. 1985a. New approaches for the evalua- tion of pulmonary toxicity: Bronchoalveolar ravage fluid analysis. Fundam. Appl. Toxicol. 5:451 - 458. Henderson, R. F., C. H. Hobbs, F. F. Hahn, J. M. Benson, J. A. Pickrell, and S. A. Silbaugh. 1985b. A com- parison of in vitm and in vivo toxicity of mineral dusts, pp. 521 - 527. In E. G. Beck and J. Bignon, Eds. In ~tro Effects of Mineral Dusts. Berlin: Springer-Verlag. Henderson, R. F., J. L. Mauderly, J. A. Pickrell, F. F. Hahn, H. Muhle, and A. H. Rebar. 1987. Compara- tive study of bronchoalveolar ravage fluid: Effect of species. Exp. Lung Res. 13:329 - 342. Henderson, R. F., J. A. Pickrell, R. K. Jones, J. D. Sun, J. M. Benson, J. L. Mauderly, and R. O. McClellan. 1988. Response of rodents to inhaled diluted diesel exhaust: Biochemical and cytological changes in bronchoaleveolar ravage fluid and in lung tissue. Fundam. Appl. Toxicol. 11:546 - 567. Henderson, Y., and H. W. Haggard. 1943. Noxious Gases and the Principles of Respiration Influencing their action. New York: Reinhold. 294 pp. Henson, P. M. 1972. Pathologic mechanisms in neutro- phil-mediated injury. Am. J. Pathol. 68:593 - 612. Henson, P. M., K. McCarthy, G. L. Larsen, R. O. Web- ster, P. C. Giclas, R. B. Dreisin, T. E. King, and J. O. Shawl 1979. Complement fragments, alveolar macrophages, and alveolitis. Am. J. Pathol. 97:93 - 110. Heyder, J. 1983. Charting human thoracic airways by aerosols. Clin. Phys. Physiol. Meas. 4:29 - 37. Hislop, A., and L. Reid. 1973. Fetal and childhood development of the intrapulmona~y veins in man: Branching pauern and structure. Thorax 28 313 319. Hnatowich, D. J., W. W. Layne, and R. L. Childs. 1982. The preparation and labeling of DTPA-coupled al- bumin. Int. J. Appl. Radiat. Isot. 33:327 - 332. Hockin~ W. G., and D. W. Golde. 1979. The pulmona~y

148 alveolar macrophage. N. Engl. J.Med.301:580 - 587. Hoffman, R. A., P. C. Kung, W. P. Hansen, and G. Gold- stein. 1980. Simple and rapid measurement of human T lymphocytes and their subclasses in peripheral blood. Proc. Natl. Acad. Sci USA 77:4914 - 4917. Hogg, J. C., P. D. Pare, and R. C. Boucher. 1979. Bronchial mucosal permit. Fed Prod 38:197 - 201. Hoidal, J. R., and D. E. Niewoehner. 1982 Lung phagm cyte recruitment and metabolic alterations induced by cigarette smoke in humans and hamsters. Am. Rev. Respir. Dis. 126:548 - 552. Hoidal, J. R., J. G. White, and J. E. Repine. 1979. Influence of cationic local anesthetics on the metabo- lism and u~ructure of human alveolar macrophaggs J. Lab. Clin. Med. 93:857 - 866. Hoidal, J. R., R. B. Fox, P. A. Lemarbe, R. Perri, and J. E. Repine. 1981. Altered oxidative metabolic responses in vitro of alveolar macrophages from asym~ somatic cigarette smokers. Am. Rev. Respir. Dis. 123:85 - 89. Holgate, S. T., and A. B. Kay. 1985. Mast cells, media- tors and asthma. Clin. Allergy 15:221 - 234. Holgate, S. T., C. Hardy, C. Robinson, R. M. Agius, and P. H. Howarth. 1986. The mast cell as a primary effecter cell in the pathogenesis of asthma. J. Allergy Clin. Immunol. 77:274 - 282. Holma, B. 1967a. Lung clearance of mono- and di-dis- perse aerosols determined by profile scanning and whole-body counting. Acta Med. Scand. 473(Suppl.~:1 - 103. Holma, B. 1967b. Short-term lung clearance in rabbits exposed to a radioactive bi-disperse (6 and 3 p) poly- styrene aerosol, pp. 189 - 201. In C. N. Davies, Ed. Inhaled Particles II. Oxford: Pergamon. Holtzman, M. J., L. M. Fabbri, P. M. O'Byrne, B. D. Gold, H. Aizawa, E. H. Walters, S. E. Alpert, and J. A. Nadel. 1983. Importance of a~rinflammation for hyperresponsiveness induced by ozone. Am. Rev. Respir. Dis. 127:686 690. Hong, R. 1976. Immunodeficiency, pp. 620 - 636. In N. R Rose and H. Friedman, Eds. Manual of Clinical Immunology. Washington, D.C.: American Society for Microbiology. Huang, F. L., D. R. Roop, and L. M. De Luca. 1986. Vitamin A deficiency and keratin biosynthesis in cultured hamster trachea. In Vitro Cell Dev. Biol. 22:223 - 230. Huff, J. E., R L. Melnick H. A. Solleveld, J. K Haseman, M. Powers, and R. A. Miller. 1985. Multiple organ carcinogenicity of 1,3 butadiene in B6C3F, mice after 60 weeks of inhalation exposure. Science 227(4686):548 - 549. Hughes, D. A., P. L. Halslam, P. J. Townsend, and M. Turner-Warwick. 1984. Blood and bronchoalveolar ravage T-subsets in sarcoidosis and extrinsic allergic alveolitis. Thorax 39:708 - 709. (Abstract.) Hugli, T. E. 1981. The structural basis for anaphylatoxin in chemotactic functions of C3a, C4a, end CSa. CRC Crit. Rev. Immunol. 1:321 - 366. REFERENCES HuIb~ W. C., D. C. Walker, A. Jackson, and J. C. Hogg. 1981. Airwaypermeabilitytohorseradishperoxidase in guinea pigs: The repair phase after injury by ciga- rette smoke. Am. Rev. Respir. Dis. 123:320 - 326. Hunninghake, G. W. 1984. Release of interleukin-1 by alveolar macrophages of patients with active pul- monary sarcoidosis. Am. Rev. Respir. Dis. 129:569 - 572. Hunninghake, G. W., and R. G. Crystal. 1981a. Mecha- nisms of hypergammaglobinemina in pulmonary sar- coidosis: Site of increased antibody production and role of T lymphocytes. J. Clin. Invest. 67:86~92. Hunninghake, G. W., and R. G. Crystal. 1981b. Pul- monary sarcoidosis: A disorder mediated by excess helper T-tmphocyte activity at sites of disease activity. N. Engl. J. Med. 305:429 - 434. Hunninghake, G. W., and R. G. Crystal. 1983. Cigarette smoking and lung destruction: Accumulation of neu- trophils in the lungs of cigarette smokers. Am. Rev. Respir. Dis. 128:833 - 838. Hunninghake, G. W., J. D. Fulmer, R. C. Young, Jr., J. E. Gadek, and R. G. Crystal. 1979a. Localization of the immune response in sarcoidosis. Am. Rev. Respir. Dis. 120:49 - 57. Hunninghake, G. W., J. E. Gadek, O. Kawanami, V. J. Ferrans, and R. G. Crystal. 1979b. Inflammatory and immune processes in the human lung in health and disease: Evaluation by bronchoalveolar ravage. Am. J. Pathol. 97:149 - 206. Hunninghake, G. W., J. E. Gadek, H. M. Fates, and R. G. Crystal. 1980a. Human alveolar macrophage derived chemotactic factors for neutrophils: Stimuli and Bestial characterization. J. CliIL West 66:4~. Hunninghake, G. W., B. A. Keogh, B. R. Line, J. E. Gadek 0. Kawanami, V. J. Ferrans, and R. G. Crystal 1980b. Pulmonary sarcoidosis: Pathogenesis and therapy, pp.27~290. In D. L. Boros and T. Yoshida, Eds. Basic and Clinical Aspects of Granulomatous Diseases. New York: Elsevier North-Holland. Hunninghake, G. W., J. E. Gadek, R. C. Young, Jr., O. Kawanami, V. J. Ferrans, and R. G. Crystal. 1980c. Maintenance of granuloma formation in pulmonary sarcoidosis byT-'ympho~tes within the lung. N. EngL J. Med. 302:594 - 498. Hunninghake, G. W., G. N. Badell, D. C. Zavala, M. Monick, and M. Brady. 1983. Role of interleukin-2 release by lung T cells in active pulmonary sarcoidosis. Am. Rev. Respir. Dis. 128:634 - 638. Hunter, J. A. A., W. E. Finkbeiner, J. A. Nadel, E. J. Goetzl, and M. J. Holtzman. 1985. Predominant generation of 15-lip~ygenase metabolites of arachidm nic acid by epithelial cells from human trachea. Proc. Natl. Acad. Sci. USA 82:4633 - 4637. Hurst, D. J., D. E. Gardner, and D. L. Coffin. 1970. Effect of ozone on acid hydrolases of the pulmonary alveolar macrophage. Res. J. Reticuloendothel. Soc. 8:288 - 301. Hutchinson, J. 1846. On the capacity of the lungs and on the respiratory movements with a view of establish

REFERENCES ing a precise and easy method of detecting disease by the spirometer. Lancet 1:630 - 632. ILO (InternationalLabour Office). 1980. Guidelines for the Use of International Labour Office Classifica- tion of Radiographs of Pneumonioniosis. Occupational Safety and Health Sciences 22. Geneva: International Labour Office. Iskander, M. F., C. H. Durney, and D. J. Shoff. 1979. Diagnosis of pulmonary edema by a surgically nonin- vasive microwave technique. Radio Sci. 14(6S):265 - 269. Incalzi, R. A., R. Pistelli, V. Locci, F. Patalano, S. M. Liberators, and G. Ciappi. 1985. Detection of ventila- tion uneveness by nitrogen washout and forced vital capacity manoeuvres: Its limits and reliability. Respi- ration 48:145 - 152. Jackson, A. C., and J. W. Watson. 1982. Oscillatory mechanics of the respiratory system in normal rats. Respir. Physiol. 48:309 - 322. Jackson, A. C., J. W. Watson, and M. I. Kotlikoff. 1984. Respiratory system, lung and chest wall impedances in anesthetized dogs. J. Appl. Physiol. 57:34 - 39. Jacobson, G., and W. S. Lainhart. 1972. ILO U/C 1971 international classification of radiographs of pneumoco- nioses. Med. Radiogr. 48:67 - 76. Jaiswal, A. K., F. J. Gonzalez, and D. W. Nebert. 1985. Human P1~50 gene sequence and correlation of mRNA with genetic differences in benzota~pyrene metabolism. Nucleic Acids Res. 13:4503 - 4520. Jakab, G. J. 1984. Viral-bacterial interactions, pp. 298 - 310. In J. Bienenstock, Ed. Immunology of the Lung and Upper Respiratory Tract. New York: McGraw-Hill. Janoff, A. 1972. Human granulocyte elastase. Further delineation of its role in connective tissue damage. Am. J. Pathol. 68:579 - 592. Jetten, A. M., and J. E. Shirley. 1986. Characterization of t~ansglutaminase activity in rabbit tracheal epithelial cells. Regulation by retinoids. J. Biol. Chem. 261:15097 - 15101. Jetten, A. M., J. I. Rearick, and H. L. Smits. 1986. Regulation of differentiation of airway epithelial cells by retinoids. Biochem. Soc. Trans. 14:930~933. Johnson, H. M., and W. L. Farrar. 1983. The role of a gamma interferon-like Iymphokine in the activation of T cells for expression of interleukin 2 receptors. Cell Immunol. 75:154 - 159. Johnson, K J., and P. A. Ward. 1982. Acute and progress she lung injury after contact with phorbal myristate acetate. Am. J. Pathol. 107:29 - 35. Johnson, K. J., J. C. Fantone, III, J. Kaplan, and P. A. Ward. 1981. In viva damage of rat lungs by oxygen metabolites. J. Clin. Invest. 67:983 - 993. Jones, J. G., B. D. Minty, P. Lawler, G. H. Hulands, J. C. Crawley, and N. Veall. 1980. Increased alveolar epithelial permeability in cigarette smokers. Lancet 1:66 - 68. Jones, R., W. M. Zapol, and L. M. Reid. 1984. Pul- monary artery remodeling and pulmonary artery hyper 149 tension after exposure to hyperopia for 7 days. A morphometric and hemodynamic study. Am. J. Pathol. 117:273 - 285. Joseph, M., A. B. Tonnel, G. Torpier, A. Capron, B. Arnoux, end d. Benveniste. 1983. Involvement of immunoglobulin E in the secretory processes of al- veolar macrophages from asthmatic patients. J. Clin. Invest. 71:221 - 230. Junttila, M. J., K. Kalliomaki, and P. L. Kalliomaki. 1983. A new magnetic method for stud the lungers rained dust in veto. Prod of the VI Internation- al Pneumoconiosis Conference. September. Kaji H., N. M. Hisamura, N. Sato, and M. Murao. 1978. Evaluation of volatile sulfur compounds in the expired alveolar gas in patients with liver cirrhosis. Clin. Chem. Acta 85:279 - 284. Kalliomaki, K, P. L. Kalliomaki, V. Kelha, and V. Vaara- nen. 1980. Instrumentation for measuring the mad netic lung contamination of steel welders. Ann. Occup. Hyg. 23:175 - 184. Kalliomaki, K., K. Aittoniemi, P. L. Kalliomaki, and M. Moilanen. 1981. Measurement of lung-retained contaminants in vivo among workers exposed to metal aerosols. Am. Ind. Hyg. Assoc. J. 42:234 - 238. Kalliomaki, K, P. L. Kalliomaki, and M. Moilanen. 1983. A new magnetic method for studying the quality of lung-retained dust in vivo. Acta. Polytechn~a Scand. App. Phys. (138~:72 - 75. Kalliomaki, K, P. L. Kalliomaki, and M. Moilanen. 1986. A mobile magnetopneumograph with dust quality sensing, pp. 215 - 218. In R. M. Stern, A. Berlin, A. C. Fletcher, and J. Jarvisalo, Eds. Heath Hazards and Biological Effects of Welding Fumes and Gases. International Congress Series, No.676. Amsterdam: Excerpta Medical Kalliomaki, P. L., K Alanko, O. Korhonen, T. Mattsson, V. Vaaranen, andM. Koponen. 1978a. Amount and distribution of welding fume and lung contaminants among arc welders. Scand. J. Work Environ. Health 4:122 - 130. Kalliomaki, P. L., O. Korhonen, V. Vaaranen, K. Kal- liomaki, and M. Koponen. 1978b. Lung retention and clearance of shipyard arc welders. Int. Arch. Occup. Environ. Health 42:83 - 90. Kalliomaki, P. L., O. Korhonen, T. Mattsson, V. Sortti, V. Vaaranen, K. Kalliomaki, and M. Koponen. 1979. Lung contamination among foundry workers. Int. Arch. Occup. Environ. Health 43:85 - 91. Kaltreider, H. B., J. L. Caldwell, and E. Adam. 1977. The fate and consequences of an organic particulate antigen instilled into bronchoalveolar spaces of normal canine lungs. Am. Rev. Respir. Dis. 116:267 - 280. Kameda, K., T. Ono, and Y. Imai. 1979. Participation of supero~de, hydrogen peroxide and hydrofoil radicals in NADPH-cytochrome P~50 reductase-catalyzed peroration of methyl linolenate. Biochem. Biophys. Acta 572:77 - 82. Kannel, W. B., E. A. Lew, H. B. Hubert, and W. P. Castelli. 1980. The value of measuring vital capacity

150 for prognostic purposes. Trans. Assoc. Life Insur. Med. Dir. Am. 64:66 - 83. Kauffmann, F. 1984. Genetics of chronic obstructive pulmonary diseases: Searching for their heterogeneity. Bull. Eur. Physiopathol. Respir. 20:163 - 210. Kawano, H., T. Inamasu, M. Ishizawa, N. Ishinishi, and J. Kumazawa. 1987. Mutagenicity of urine from young male smokers and nonsmokers. Int. Arch. Occup. Environ. Health 59:1 - 9. Kehrl, H. R., L. M. Vincent, R. J. Kowa~y, D. H. Horst- man, J. J. O'Neil, W. H. McCartney, and P. A. Brom- berg. 1987. Ozone exposure increases respiratory epithelialpermeabilityin humans. Am. Rev. Respir. Dis. 135:1124 - 1128. Kejeldgaard, J. M., R. W. Hyde, D. M. Speers, and W. W. Reichert. 1976. Frequency dependence of total respiratory resistance in early airway disease. Am. Rev. Respir. Dis. 114:501 - 508. Keller, R. H., S. Swartz, D. P. Schlueter, S. Bar-Sela, and J. N. Fink. 1984. Immunoregulation in hypersen- sitivitypneumonitis: Phenotypic and functional studies of bronchoalveolar ravage lymphocytes. Am. Rev. Respir. Dis. 130:766 - 771. Kelly, J., D. Hemenway, and J. N. Evans. 1986. Hydro~yl- ysine as a marker of lung injury in nitrogen dioxide exposure. Am. Rev. Respir. Dis.133 A86. (Abstract.) Kennedy, S. M., R. K. Elwood, B. J. R. Wiggs, P. D. Pare, and J. R. How. 1984. Increased airw~mucosal permability of smokers: Relationship to airway reac- tivity. Am. Rev. Respir. Dis. 129:143 - 148. Kerns, W. D., D. J. Donofrio, and K. L. Pavkov. 1983. The chronic effects of formaldehyde inhalation in rats and mice: A preliminary report, pp. 111 - 131. In J. E. Gibson, Ed. Formaldehyde Toxicity. Washing- ton, D.C.: Hemisphere. Kerr, J. S., D. J. Riley, M. M. Frank, R. L. Trelsted, and H. M. Frankel. 1984. Reduction of chronic hypcxic pulmonary hypertension in the rat by B-amino- propionitrile. J. Appl. Physiol. 57:176~1766. Kerr, J. S., C. L. Ruppert, C. A. Tozzi, J. A. Neubauer, H. M. Frankel, S. Y. Yu, and D. J. Riley. 1987. Reduction of chronic hypoxia pulmonary hypertension in the rat by an inhibitor of collagen production. Am. Rev. Respir. Dis. 135:300 306. Khan, M. M., and K. Melmon. 1985. Are autocoids more than theoretic modulators of immunity? Clin. Immumol. Rev. 4:1 - 30. Kidd, V. J., R. B. Wallace, K. Itakura, and S. L. Woo. 1983. Alpha 1-antit~ypsin deficiency defection by direct analysis of the mutation in the gene. Nature 304(5923):23~234. Kim, C. S., L. K. Brown, G. G. Lewars, and M. A. Sack- ner. 1983. Aerosol rebreathing method for assessment of airway abnormalities: Theoretical analysis and validation. Am. Ind. Hyg. Assoc. J. 44:349 - 357. Kim, C. S., G. A. Lewars, and M. A. Sackner. 1985. Total aerosol deposition as an index of lung abnor- mality. Presented at American Association for Aerosol Research, Annual Meeting, Albuquerque, REFERENCES New Mexico, November 1985. Kim, K J., T. R. LeBon, J. S. Shinbane, and E. D. Cran- dall. 1985. Asymmetric i4C-albumin transport across bullfrog alveolar epithelium. J. Appl. Physiol. 59:12901297. Kimura, A., and E. Goldstein. 1981. Effect of ozone on concentrations of fine in phag~g alveolar marcophages. J. Infect. Dis. 143:247 - 251. Kirby, J. G., P. M. O'Byrne, and F. E. Hargreave. 1987. Bronchoalveolar ravage does not alter answer respon- s*eness in asthmatic subjects. Am. Rev. Respir. Dis. 135:554 - 556. Klech, H., P. Haslam, and M. Turner-Warwick. 1986. World wide clinical survey on bronchoalveolar Wage (BALI in sarcoidosis. Experience in 62 centers in 19 countries. Preliminary analysis. Sarcoidosis 3:113 - 117. Knight, D. R., H. J. O'Neill, S. M. Gordon, E. H. Lueb- cke, and J. S. Bowman. 1984. The Body Burden of Organic Vapors in Artificial Air: Trial Measure- mentsAboard a Moored Submarine. Memo Report 84 4. Groton, Conn.: Naval Submarine Medical Research Laboratory. Knight, D. R., J. O'Neill, J. S. Bowman, and S. M. Gor- don. 1985. Use of the expired breath to monitor the air quality in sealed capsules. Physiologist 28 336. (Abstract.) Knowles, M. R., J. L. Carson, A. M. Collier, J. T. Gatzy, end R. C. Boucher. 1981. Measurements of nasal ~ithelial electric potential differences in nonnal human subjects in viva. Am. Rev. Respir. Dis. 124:484 - 490. Knowles, M. R., W. H. Buntin, P. A. Bromberg, J. T. Gatzy, and R. C. Boucher. 1982. Measurements of transepithelial electric potential differences in the trachea and bronchi of human subjects in vivo. Am. Rev. Respir. Dis. 126:108 - 112. Knowles, M. R., J. T. Gatzy, and R. C. Boucher. 1983. Relative ion permeability of normal and cystic fibrosis nasal epithelium. J. Clin. Invest. 71:141~1417. Knowles, M. R. G. Murray, J. Shallal, F. Awn, V. Eland, J. Gatzy, and R. Boucher. 1984. Bioelectric properties and ion flow across excised human bronchi. J. Appl. Physiol. 56:868 - 877. Knowles, M. R., J. T. Gatzy, and R. C. Boucher. 1986. Measurement of canine tracheal epithelial resistance invivo. Am. Rev. Respir. Dis. 133:A90. (Abstract.) Koenig,J. Q., end W. E. Pierson. 1984. Nasalresponses to air pollutants. Clin. Rev. Allergy 2:255 - 261. Koenig, J. Q., D. S. Covert, S. G. Marshall, G. Van Belle, and W. E. Pierson. 1987. The effects of ozone and nitrogen dioxide on pulmonary function in healthy and in asthmatic adolescents. Am. Rev. Respir. Dis. 136:1152 - 1157. Koponen, M., T. Gustafsson, K. Kalliomaki, P. L. Kal- liomaki, M. Moilanen, and L. Pyy. 1980. Dusts in a steel making plant: Lung contamination among iron workers. Int. Arch. Occup. Environ. Health 47:35 - 45.

REFERENCES Koren, H. S., R. B. Devlin, D. E. Graham, R. Mann, M. P. McGee, D. H. Horstman, W. J. Kozumbo, S. Becker, D. E. House, W. F. McDonnell, and P. A. Bromberg. 1989. Ozone-induced inflammation in the lower airways of human subjects. AN Rev. Respir. Dis. 139:407-415. Koretzky, G. A., J. A. Elias, S. L. Kay, M. D. Rossman, P. C. Nowell, and R. P. Daniele. 1983. Spontaneous production of interleukin-1 by human alveolar macro- phages. Clin. ImmunoL Immunopathol.29:443 - 450. Krotos~ynski, B., G. Gabriel, and H. O'Neill. 1977. Characterization of human expired air: A promising investigative and diagnostic technique. J. Chromatogr. Sci. 15:239 - 244. Kulle, T. J., S. A. J. Goings, L. R. Sauder, D. J. Green, and M. L. Clements. 1987. Susceptibility to virus infection with NO2 exposure. Am. Rev. Respir. Dis. 135~4 Pt. 23 A58. (Abstract.) LaBelle, C. W., D. M. Bevilacqua, and H. Brieger. 1964. Synergic effects of aerosols IV. Therapeutic elimi- nation of inhaled radioactive particles. J. Occup. Med. 6:391 - 395. Lam, S., F. Tan, H. Chan, and M. Chan-Yeung. 1983. Relationship between types of asthmatic reaction, nonspecific bronchial reactivity, and specific IgE an- tibodies in patients with red cedar asthma. J. Allergy Clin. Immunol. 72:134 - 139. Lambre, C. R., S. Le Maho, G. Di Bella, H. De Cre- mous, KAtassi, end d. Bignon. 1986. Bronchoalveolar ravage fluid and semm complement activity in pul- monary sarcoidosis. Am. Rev. Respir. Dis. 134:238 - 247. Lamontagne, L., J. Gauldie, A. Stadnyk, C. Richards, and E. Jenlcins. 1985. In viva initiation of unstimu- lated in vitro interleukin-1 release by alveolar macro- phages. Am. Rev. Respir. Dis. 131:326 - 330. Landahl, H. D. and R. G. Hermann. 1950. Retention of vapors and gases in the human nose and lung. AMA Arch. Ind. Health 1:36 - 45. Lapp, N. L., J. L. Hankinson, H. Amandus, and E. D. Palmes. 1975. Variability in the size of airspaces in normal human lungs as estimated by aerosols. Thorax 30:293 - 299. Larsen, G. L., B. C. Mitchell, T. B. Harper, and P. M. Henson. 1982. The pulmonary response of C5 suff~- cient and deficient mice to Pseudomonas aen'~nosa. Am. Rev. Respir. Dis. 126:306 - 311. Laurenzi, G. A., and J. J. Guarneri. 1966. Effects of bacteria and viruses on ciliated epithelium. A study of the m~ar~ru; of pulmonary resistance to infection The relationship of bacterial clearance to ciliary and alveolar macrophage function. Am. Rev. Respir. Dis. 93S:1:~ 141. Lanwreys, R. R. 1983. Industrial Chemical Exposure: Guidelines for Biological Monitoring. Davis, Calif.: Biomedical Publications. 150 pp. Laviolette, M. 1985. Lymphopyte fluctuation in broncho- alveolar ravage fluid in normal volunteers. Thorax 40:651 - 656. 151 Laviolette, M., J. Chang, and D. S. Newcombe. 1981. Human alveolar macrophages: A lesion in arachidonic acid metabolism in cigarette smokers. Am. Rev. Respir. Dis. 124:397 - 401. Leatherman, J. W., A. F. Michael, B. A. Schwartz, and J. R. Hoidal. 1984. Lung T cells in hypersensitivity pneumonitis. Ann. Intern. Med. 100:390392. Lee, C. T., A. M. Fein, M. Lippmann, H. Holtzman, P. Kimbel, and G. Weinbaum. 1981. Elastol~rtic activity in pulmonarylavage fluid from patients with adult respiratory-distress syndrome. N. EngL J. Med. 304:192 - 196. Lehnert, B. E., J. E. London, A. J. Vanderkegel, J. G. Valdez, and L. R. Gurley. 1986. HPLC analyses of ravage fluid constituents following environmental insults. Toxicologist 6:138. (Abstract.) Leikauf, G., D. B. Yeates, K. A. Wales, D. Spektor, R. E. Albert, and M. Lippmann. 1981. Effects of sulfite acid aerosol on respiratory mechanics and mucocDiary particle clearance in healthy non-smoking adults. Am. Ind. Hyg. Assoc. J. 42:273 - 282. Leith, D. E., and J. Mead. 1974. Principles of Body Plethysmography. Bethesda, My:] Division of Lung Diseases, National Heart and Lung Institute. Lem, V. M., M. F. Lipscomb, J. C. Weissler, G. Nunez, E. J. Ball, P. Stastny, and G. B. Toews. 1985. Bron- choalveolar cells from sarcoid patients demonstrate enhanced antigen presentation. J. Immunol. 135:1766 1771. Le Mesurier, S. M., B. W. Steward, and A. W. J. Lykke. 1981. Injury to type-2 pneumocytes in rats exposed to cigarette smoke. Environ. Res. 24:207 - 217. Leslie, C., K McCormick-Shannon, J. Cook, and R. Mason. 1985. Macrophages stimulate DNA synthesis in rat alveolar Type II cells. Am. Rev. Respir. Dis. 132:1246. Lewis, F. F., V. B. Elings, S. L. Hill, and J. M. Christen- sent 1982. The measurement of intravascular lung wafer by thermal-green dye indicator dilution. Ann. N.Y. Acad. Sci. 384:394 - 410. Lewis, R. A. 1985. A presumptive role for leukotrienes in obstnlctive airways diseases. Chest 88 (Suppl. 2~:98S-102S. Lewis, R. A., and K F. Austen. 1984. The biologically active leukotrienes: Biosynthesis, metabolism, recep tars, functions and pharmacology. J. Clin. Invest. 73:889 - 897. Lima, M., and R E. Rocldin. 1981. E~am~e modulates in vitro IgG production bypokeweed mitogen-stimula- ted human mononuclear cells. Cell. Immunol. 64:324 336. Lippmann, M. 1988. Rapporteur's Report. Session XI-U.S.-Dutch Ozone Symposium, May 11, 1988. [U.S.-Dutch Ozone Meeting, held May 9 - 13, 1988 in Niimegen, The Netherlands.l 5 pp. I)ppmann, M., and R B. Schlesinger. 1984. Intervenes comparisons of particle deposition and mucociliary clearance in tracheobronchial airways. J. Toxicol. Environ. Health 13:441 - 469.

152 Lippmann, M., D. B. Yeates, and R. E. Albert. 1980. Deposition, retention, and clearance of inhaled par- ticles. Br. J. Ind. Med. 37:337 - 362. Little, C. D., M. M. Nau, D. N. Carney, A. F. Gazdar, and J. D. Minna. 1983. Amplification and expression of the ~myc oncogene in human lung cancer cell lines. Nature 306:194 - 196. Little, J. W., W. J. Hall, R. G. Douglas, Jr., G. S. Mud- holkar, D. M. Speers, and K. Patel. 1978. Airway hyperreactivity and peripheral airway dysfunction in influenza A infection. Am. Rev. Respir. Dis. 118:295 - 303. Liu, M. C., D. Proud, R. P. Schleimer, and M. Plaut. 1984. Human lung macrophages enhance and inhibit lymphocyte proliferation. J. Immunol. 132:2895 - 2903. Loo, B. W., F. S. Gouldings, and D. S. Simon. 1986. A new compton densitometer for meamnng pulmonary edema. IEEE Trans. Nucl. Sci. 33:531 - 536. Lorin, M. I., P. F. Gaerlan, and I. D. Mandel. 1972. Quantitative composition of nasal secretions in normal subjects. J. Lab. Clin. Med. 80:275 - 281. Loudon, R., and R. L. H. Murphy, Jr. 1984. Lung sounds. Am. Rev. Respir. Dis. 130:663 - 673. Lourenco, R. V., E. D. Stanley, B. Gatmaiton, and G. G. Jackson. 1971a. Abnormal deposition and clear- ance of inhaled particles during upper respiratory viral infections. J. Clin. Invest. 50:62a. (Abstract.) Lourenco, R. V., M. F. Klimek, and C. J. Borowski. 1971b. Deposition and clearance of 2-p particles in the tracheobronchial tree of normal subjects-smokers and non-smokers. J. Clin. Invest. 50:1411 - 1419. Low, R. B., G. S. Davis, and M. S. Giancola. 1978. Biochemical analysis of bronchoalveolar ravage fluids of healthy human volunteer smokers and nonsmokers. Am. Rev. Respir. Dis. 118:863 - 875. Lucas, R. M., V. G. Iannacchione, and D. K. Melroy. 1982. Polychlorinated Biphenyls in Human Adipose Tissue and Mother's Milk. Washington, D.C.: U.S. Environmental Protection Agency. Luchsinger, P. C., B. LaGarde, and J. E. Kilfeather. 1968. Particle clearance from the human tracheobron- chial tree. Am. Rev. Respir. Dis. 97:1046 1050. Luster, M. I., A. E. Munson, P. T. Thomas, M. P. Holsap- ple, J. D. Fenters, K. L. White, Jr., L. D. Lauer, D. R. Germolec, G. J. Rosenthal, and J. H. Deans. 1988. Development of a testing battery to assess chemical-inducedimmunotoxicity NationalTo~cology Program's guidelines for immunotoxicity evaluation in mice. Fundam. Appl. Toxicol. 10:2-19. Maccia, C. A., I. L. Bernstein, E. A. Emmett, and S. M. Brooks. 1976. In vitm demonstration of specific IgE phthalic anhydride hypersensitivity. Am. Rev. Respir. Dis. 113:701 - 704. MacGlashan, D., Jr., R. P. Schleimer, J. S. Peters, E. S. Schulman, G. K Adam$ A. K Sobotka, H. Newball, and L. M. Lichtenstein. 1983. Comparative studies of human basophils and mast cells. Fed. Prod. 42:2504-2509. Macklem, P. T. 1974. Procedures For Standardized REFERENCES Measurements of Lung Mechanics. Measurement of Esophageal P~ure. Meamrmnent of {zing Mesh nice. [Bethesda, Md.:] Divison of Lung Diseases, National Heart and Lung Institute. Macklem, P. T., and M. R. Be~lake. 1963. The relation- ship between the mechanical and diffusing properties of the lung in health and disease. Am. Rev. Respir. Dis. 87:47 - 56. Macklin, C. C. 1955. Pulmonary sumps, dust accumula- tions, alveolar fluid, and lymph vessels. Acta Anat. (Basal) 23:1 - 21. Majima, Y., Y. Sakakura, T. Matsubara, S. Mural, and Y. Miyoshi. 1983. Mucociliary clearance in chronic sinusitis: Related human nasal clearance andin vitro bullfrog palate clearance. Biorheology 20:251 - 262. Maim, L., J. Wihl, C. Lamm, and N. Lindqvist. 1981. Reduction of metacholine-induced nasal secretion by treatment with a new topical steroid in perennial non-allergic rhinitis. Allergy 36:209 - 214. Malmberg H., and E. Holopainen. 1979. Nasal smear as a screening test for immediate-type nasal allergy. Allergy 34:331 - 337. Man, S. F. P., T. K. Lee, R. T. N. Gibney, J. W. Logus, and A. A. Noujaim. 1980. Canine tracheal mucus transport of particulate pollutants: Comparison of radiolabeled corn pollen, ragweed pollen, asbestos, silica, and talc to Dowex anion exchange particles. Arch. Environ. Health 35:283 - 286. Marcy, T. W., W. W. Merrill, J. A. Rankin, and H. Y. Reynolds. 1987. Limitations of using urea to quantify epithelial lining fluid recovered by bronchoalveolar ravage. Am. Rev. Respir. Dis. 135:1276 - 1280. Marom, Z., J. Shelhamer, and M. Kaliner. 1984. Nasal mucus secretion. Ear Nose Throat J. 63:36 - 7,41 - 2, 44 . Martin, B. M., M. A. Gimbrone, Jr., E. R. Unanue, and R. S. Coltran. 1981. Stimulation of nonlymphoid mesenchymal cell proliferation by a macrophage-deri- ved growth factor. J. Immunol. 126:151~1515. Martin, R., and P. T. Macklem. 1973. Suggested Stand- ardized Peres for agog Volume Deteminadons (Nitrogen Method). Bethesda, Md.: Division of Lung Diseases, National Heart and Lung Institute. 7 pp. Martin, R. R., D. Lindsay, P. Despas, D. Brace, M. Lerolux, N. R. Anthonisen, and P. T. Macklem. 1975. The early detection of airway obstruction. Am. Rev. Respir. Dis. 111:119 - 125. Martin, T. R., G. Raghu, R. J. Maunder, and S. C. Spring- meyer. 1985. The effects of chronic bronchitis and chronic air-flow obstruction on lung cell populations reowered by bronchoakeolar lineage. And Rev. Respir. Dis. 132:254 - 260. Martin, W. J., 2d, J. E. Gadek, G. W. Hunnighake, and R. G. Crystal. 1981. (oxidant injury of lung parenchy- mal cells. J. Clin. Invest. 68:1277 - 1288. Mason, G. R., J. M. Uszler, R. M. Effros, and E. Reid. 1983. Rapidly reversible alterations of pulmonary epithelial permeability induced by smoking. Chest 83:6 - 11.

REFERENCES Mason, M. J., D. E. Bice, and B. A. Muggenburg. 1985. Local pulmonary immune responsiveness after multiple antigenic exposures in the cynomolgus monkey. Am. Rev. Respir. Dis. 132:657 - 660. Mauderly, J. L. 1977. Bronchopulmonary ravage of small laboratory animals. Lab. Anim. Sci. 27:255 - 261. Mauderly, J. L., B. A. Muggenburg, F. F. Hahn, and B. B. Boecker. 1980. The effects of inhaled 144Ce on cardiopulmonary function and histopathology of the dog. Radiat. Res. 84:307 - 324. McAllen, S. J., S. P. Chiu, R. F. Phalen, and R. E. Ras- mussen. 1981. Effect of in Gino ozone exposure onin vim pulmonary alveolar macrophage mobility. J. Toxicol. Environ. Health 7:373 - 381. McCarthy, D. S., R. Spencer, R. Greene, and J. Mili~Emili 1972. Measurement of "closing volume" as a simple and sensitive test for early detection of small airway disease. Am. J. Med. 52:747 - 753. McCawley, M. 1987. An aerosol bolus dispersion test compared to indices of lung disease. Ph.D. Disserta- tion, New York University, N.Y. McCawley, M., and M. Lippmann. 1984. An aerosol dispersion test: Comparison of results from smokers and non-smokers, pp. 1007 - 1010. In B. Y. H. Liu, D. Y. H. Put, and H. J. Fissan, Eds. Aerosols: Sci- ence, Technology and Industrial Applications of Air- borne Particles. Prod of the First International Aerosol Conference held September 17 - 21,1984, Minneapolis, Minnesota. New York: Elsevier. McClellan, R. O. 1986. Health effects of diesel exhaust: A case study in risk assessment. Am. Ind. Hyg. Assoc. J. 47:1 - 13. McCormick, J. R., and J. D. Catravas. 1986. Changes in the kinetics of pulmonary angiotensin-converting enzyme (ACE) and 5'-nucleotidase (NCT) following endothelial cell injurywith phorbol myristate acetate (PMA). Am. Rev. Respir. Dis. 133:Al9. (Abstract.) McKay, R.T. 1986. Bronchoprovocation challenge testing in occupational airways disorders. Semin. Respir. Med. 7:297 - 306. McLean, J. A., A. A. Ciarkowski, W. R. Solomon, and K P. Mathews. 1976. An improved technique for nasal inhibition challenge tests. J. Allergy Clin. Im- munol. 57:153 - 163. McMahon, T. A., J. D. Brain, and S. LeMott. 1977. Species difference in aerosol deposition, pp. 23 - 33. In W. H. Walton, Ed. Inhaled Particles IV, Pt. 1. Oxford: Pergamon. Mead, J., and E. Agostoni. 1964. Dynamics of breathing, pp. 411 - 427. In W. O. Penn and H. Rahn, Eds. Handbook of Plysiology, Section 3, Volume 1, R - ra lion. Bethesda, Md.: American Physiological Society. Mecham, R. P., L. A. Whitehouse, D. S. Wrenn, W. C. Parks, G. L. Griffin, R. M. Senior, E. C. Crouch, K. R. Stenmark, end N. F. Voelkel. 1987. Smooth mum cle-mediated connective tissue remodeling in pulmonary hypertension. Science237~4813~:423~26. May, M. A., J. A. Dutcher, J. A. Bond, R. F. Hender- son, J. L. Mauderly, M. B. Snipes, J. A. Mewhinney, 153 Y. S. Cheng, and L. S. Birnbaum. 1985. Uptake and excretion of [ICY methyl bromide as influenced by exposure concentration. Toxicol. Appl. Pharmacol. 78:215 - 225. Medinsky, M. A., P. J. Sabourin, G. Lucier, L. S. Birn- baum, and R. F. Henderson. In press a A physiolog~- cal model for simulation of benzene metabolism by rats and mice. Tomcol. Appl. Pharmacol. Medinsky, M. A., P. J. Sabounn, R. F. Henderson, G. W. Lucier, and L. S. Birnbaum. In press b. Differen- ces in the pathways for metabolism of benzene in rats and mice simulated by a physiological model. Environ. Health Perspect. 82. Merrill, W. W., J. G. Bartlett, and H. Y. Reynolds. 1982. Applied immunology of the lung, pp. 167 - 188. In D. H. Simmons, Ed. Current Pulmonology, Vol. 4. New York: John Wiley & Sons. Metcalfe, D. D., M. Kaliner, and M. A. Donlon. 1981. The mast cell. CRC Crit. Rev. Immunol. 3:23 - 74. Metzger, W. J., K. Nugent, H. B. Richerson, P. Moseley, R. Lakin, D. Zavala, and G. W. Hunninghake. 1985. Methods for bronchoalveolar ravage in asthmatic patients following bronch~provocation and local challenge. Chest 87(Suppl. 1~:16S-ITS. Metzger, W. J., D. Zavala, H. B. Richerson, P. Moseley, P. Iwamota, M. Monick, K Sjoerdsma, and G. W. Hunninghake. 1987. Local allergen challenge end bronchoalveolar ravage of allergic asthmatic lungs: Description of the model and local airway inflamma- tion. Am. Rev. Respir. Dis. 135:433 - 440. Meyrick, B., and K. L. Brigham. 1986. Repeated Es- cherichia cold endot~n-induced pulmonary irdlanuna- tion causes chronic pulmonary hypertension in sheep. Structural and functional changes. Lab. Invest. 55:164 - 176. Meyrick, B., and L. Reid. 1978. The effect of continued hypoxia on rat pulmonary arterial circulation. An ultrastructural study. Lab. Invest. 38:188 - 200. Meynck, B., and L. Reid 1979a. Ultrastructural features of the distended pulmonary arteries of the normal rat. Anat. Rec. 193:71 - 97. Meync k, B., and L. Reid. 1979b. Hypoxia and incotpora- tion of 3H-thymidine by cells of the rat pulmonary arteries and alveolar wall. Am. J. Pathol. 96:51 - 70. Meynck, B., and L. Reid. 1980. Endothelial and sum intimal changes in rat hilar pulmonary artery during recovery from hypoxia A quantitative ultrastructural study. Lab. Invest. 42:603 - 615. Meyrick, B., and L. Reid. 1983. Pulmonary hypertension. Anatomic and physiologic correlates. Clin. Chest Med. 4:199 - 217. Meyrick, B., W. Gamble, and L. Reid. 1980. Develop- ment of Crotalaria pulmonary hypertension: Hemody- namic and structural study. Am. J. Physiol. 239:H692-H702. Mpyrick, B., E. A. Perkett, and K. L. Brigham. 1987. Inflammation and models of chronic pulmonary lyper- tension. Am. Rev. Respir. Dis. 136:765 - 767. Merry, R. J., M. A. Cohn, R. J. Fernandez, ~ J. Janusiki

154 ewicz, and A. Wanner. 1978. Mucociliary transport in allergic patientswith antigen-induced bronchospasm. Am. Rev. Respir. Dis. 118:677 - 684. Miadonna, A., E. Leggieri, A. Tedeschi, and C. Zanussi. 1983. Clinical significance of specificIgE determina- tion on nasal secretion. Clin. Allergy 13:155 - 164. Miller, B. E., R. E. Chapin, L. B. Gilmore, K. E. Pinker- ton, and G. E. R. Hook. 1986. Silica induced prolifer- ation of alveolar type II cells: Quantitation by alkaline phosphatase histochemistry. Toxicologist 6:133. (Abstract.) Miller, B. E., R. E. Chapin, K. E. Pinkerton, L. B. Gil- more, R. R. Maronpot, and G. E. R. Hook. 1987. Quantitation of silica-induced type II cell hyperplasia by using alkaline phosphatase histochemistry in glow methac~ylate embedded lung. Exp. Lung Res. 12:135 - 148. Miller, F. J., J. W. Illing, and D. E. Gardner. 1978. Effect of urban ozone levels on laboratory-induced respiratory infections. Toxicol. Lett. 2:163 - 169. Miller, F. J., J. H. Overton, E. T. Myers, and J. A. Graham. 1982. Pulmonary dosimetry of nitrogen dioxide in animals and man, pp. 377 - 386. In T. Schnei- der and L. Grant, Eds. Air Pollution by Nitrogen Oxides: Proceedings of U.S.-Dutch International Symposium, Maastricht, The Netherlands. Studies in Environmental Science, 21. Amsterdam: Elsevier. Miller, F. J., J. H. Overton, Jr., R. H. Jaskot, and D. B. Menzel. 1985. A model of the regional uptake of gaseous pollutants in the lung. I. The sensitivity of the uptake of ozone in the human lung to lower respiratory tract secretions and exercise. Toxicol. Appl. Pharmacol. 79:11 - 27. Miller, F. J., J. H. Overton, Jr., E. D. Smolko, R. C. Graham, and D. B. Menzen. 1987. Hazard assessment using an integrated physiologically-based dosimet~y modeling approach: Ozone, pp. 353 - 368. In Phar- macokinetics in Risk Assessment. Drinking Water and Health, Vol. 8. Washington, D.C.: National Academy Press. Miller, R. E., J. L. Paradise, G. A. Friday, P. Fireman, and D. Voith. 1982. The nasal smear for eosinophils: Its value in children with seasonal allergic rhinitis. Am. J. Dis. Child. 136:1009 - 1011. Milne, E. N. C., M. Pistolesi M. Miniati and C. Guintini. 1985. The radiologic distinction of cardiogenic and noncardiogenic edema. Am. J. Roentgen. 144:87~. Mintun, M. A., D. R. Dennis, M. J. Welch, C. J. Mathias, and D. P. Schuster. 1987. Measurements of pulmonary vascular permeability with PET and gallium~8 transfer- rin. J. Nucl. Med. 28:1704 - 1716. Minty, B. D., and D. Royston. 1985. Cigarette smoke induced changes in rat pulmonary clearance of 99 - c-DTPA: A comparison of particulate and gas phases. Am. Rev. Respir. Dis. 132:1170 - 1173. Mishra, B. B., L. W. Poulter, G. Janossy, S. Sherlock, and D. G. James. 1986. The Kveim-Siltzbach granuloma: A model for sarcoid granuloma formation. Ann. N.Y. Acad. Sci. 465:164 - 175. REFERENCES Miskulin, M., R. Dalgleish, B. Kluve-Beckerman, S. I. Rennard, P. Tolstoshev, M. Brantly, and R. G. C~ystal. 1986. Human type III collagen gene expression is coordinately modulated with the type I collagen genes during fibroblast growth. Biochemistly 25:1408 1413. Mizel, S. B. 1982. Interleukin 1 and T cell activation. Immunol. Rev. 63:51 - 72. Mohtashamipur, E., K. Norpoth, and F. Lieder. 1985. Isolation of frameshift mutagens from smokers' urine: Experience with three concentration methods. Car- cinogenesis 6:783 - 788. Monaco, A. P., R. L. Neve, C. Colletti-Feener, C. J. Bertelson, D. M. Kurrut, and L. M. Kunkel. 1986. Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene. Nature 323:646 650. Monaco, A. P., C. J. Bertelson, C. Colletti-Feener, and L. M. Kunkel. 1987. Localization and cloning of Xp21 deletion breakpoints involved in musa~lar dystrm phy. Hum. Genet. 75:221 - 227. Monick, M., J. Glazier, and G. W. Hunninghake. 1987. Human alveolar macrophages suppress interleukin-1 (Il-l) activity vie the secretion of prostaglandin E22. Am. Rev. Respir. Dis. 135:72 - 77. Moore, V. L., G. M. Pedersen, W. C. Hauser, and J. N. Fink. 1980. A study of lung ravage materials in patients with hypersensitivity pneumonitis: In vitro response to mitogen and antigen in pigeon breeders' disease. J. Allergy Clin. Immunol. 65:365 - 370. Moores, S. R., S. E. Sykes, A. Morgan, N. Evans, J. C. Evans, and A. Holmes. 1980. The short-term cellular and biochemical response of the lung to toxic dusts: An in vivo cytotoxicity test, pp. 297 - 303. In R. C. Brown, I. P. Gormley, M. Chamberlain, and R. Davies, Eds. The In ~tr~ Effect of Mineral Dusts. New York: Academic Press. Morgan, A., A. Black, J. C. Evans, E. H. HadBleld, R. G. Macbeth, and M. Walsh. 1973. Impairment of nasal mucociliary clearance in wood workers in the furniture industry, pp. 335 - 338. In Proceedings of First International Congress on Aerosols in Medicine, 19 - 21 September 1973, Baden/Wien, Austria. Baden/Wien: Internationale Gesellschaft fur Aerosole in der Medizin. Morgan, A., S. R. Moores, A. Holmes, J. C. Evans, N. H. Evans, and A. Black. 1980. The effect of quartz, administered by intratracheal instillation, on the rat lung. I. The cellular response. Environ.Res.22:1 - 12. Morley, A. A., K J. Trainor, R. Seshadri and R. G. Ryall. 1983. Measurement of in vivo mutations in human lymphocytes. Nature 302:155 - 156. Mornex, J. F., Y. Martinet, K Yamauchi P. B. Bitterman, G. R. Grotendorst, A. Chytil-Weir, G. R. Martin, and R. G. Crystal. 1986. Spontaneous expression of the c-sis gene and release of a platelet-derived growth factorl~e molecule by human alveolar macro- phages. J. Clin. Invest. 78:61 - 66. Morris, A. H., D. D. Blatter, T. A. Case, A. G. Cutillo, D. C. Ailion, C. H. Durney, and S. A. Johnson. 1985.

REFERENCES A new nuclear magnetic resonance property of lung. J. Appl. Physiol. 58:759 - 762. Morris, J. B., and D. G. Cavanagh. 1986. Deposition of ethanol and acetone vapors in the upper respiratory tract of the rat. Fund. Appl. Toxicol. 6:78 - 88. Morns, J. B., R. J. Clay, and D. G. Cavanagh. 1986. Species differencesin upper respiratory tract deposition of acetone end ethanolvapors. Fundam.AppLTo'acoL 7:671 - 68~0. Mod B., and P. Camner. 1980. Impaired mucodiary transport as a pathogenetic factor in obstrutive pul- monary diseases. Chest 77(Suppl. 23:265 - 266. Muggenburg, B. A., J. L. Mauderly, J. A. Pickrell, T. L. Chifelle, R. K. Jones, U. C. Luft, R. O. McClellan, and R. C. Pfleger. 1972. Pathophysiologic sequelae of bronchopulmonary ravage in the dog. Am. Rev. Respir. Dis. 106:219 - 232. Muggenburg, B. A., F. F. Hahn, J. A. Bowen, and D. E.Bice. 1982. Flexible f~beropticbronchoscopyof chimpanzees. Lab. Anim. Sci. 32:534 - 537. Muir, D. C. F. 1970. The effect of airways obstruction on the single breath aerosol curve, pp.319 - 325. In A. Bouhuys, Ed. Airway Dynamics: Physiology and Pharmacology. Springfield, Ill.: Charles C Thomas. Muller-Quernheim, J., C. Saltini, P. Sondermeyer, and R. G. Crystal. 1986. Compartmentalized actuation of the interleukin 2 gene by lung T lymphocytes in active pulmonary sarcoidosis. J. Immunol. 137:3475 - 3483. Mundie, T. G., C. Whitener, and S. K. Ainsworth. 1985. l~inosis: Release of prostaglandins, thromboxanes, and 5-hydrmyt~yptamine in bronchopulmonary ravage fluid after inhalation of cotton dust extracts. Am. J. Pathol. 118:128~133. Murray, J. J., A. B. Tonnel, A. R. Brash, L. J. Roberts, 2d, P. Gosset, R. Workman, A. Capron, and J. A. Oates. 1986. Release of prostag andin D2 into human airways during acute antigen challenge. N. Engl. J. Med. 315:800804. Mygind, N., B. Weeke, and S. Unman. 1975. Quantitative determination of immunoglobulins in nasal secretion. Int. Arch. Allergy Appl. Immunol. 49:99 - 107. Naclerio, R. M., H. L. Meter, A. Kagey-Sobotka, N. F. Adkinson, Jr., D. A. Meyers, P. S. Norman, and L. M. Lichtenstein. 1983. Mediator release after nasal airway challenge with allergen. Am. Rev. Respir. Dis. 128:597 - 602. Naclerio, R M., D. Proud, A. G. Togias, N. F. Adldnson, Jr., D. A. Meyers, A. Kagey-Sobotka, M. Plaut, P. S. Norman, and L. M. Lichtenstein. 1985. Inflam- matory mediators in late antigen-induced rhinitis. N. Engl. J. Med. 313:65 - 70. Nadel, J. A., and P. J. Barnes. 1984. Autonomic regula- tion of the always. Annul Rev. Med. 34:451 - 467. Nebert, D. W., and F. J. Gonzalez. 1987. P450 genes: Structure, evolution, and regulation. Annul Rev. Biochem. 56:945 - 993. Neiman, P. E., W. Reeves, G. Ray, N. Flournoy, K. G. Lerner, G. E. Sale, and E. D. Thomas. 1977. A 155 prospective analysis of interstitial pneumonia and opportunistic viral infection among recipients of al- logeneic bone marrow grafts. J. Infect. Dis. 136:754 - 767. Nemery, B., N. E. Moavero, L. Brasseur, and D. C. Stanescu. 1981. Significance of small airway tests in middle-aged smokers. Am. Rev. Respir. Dis. 124:232 - 238. Newmann, H.-G. 1984. Analysis of hemoglobin as a dose monitor for aviating and aryla~g agents. Arch Toxicol. 56:1 - 6. Newman Taylor, A. J., J. R. Myers, J. L. Longbottom, D. Spackman, end A. J. M. Slovak 1981. Immunologi- cal differences between asthma and other allergic reactions in laboratory animal workers. Thorax 36:229. (Abstract.) NHLBI (National Heart, Lung and Blood Institute). 1985. Summary and recommendations of a workshop on the investigative use of fiberoptic bronchoscopy end bronchoalveolar ravage in asthmatics. Am. Rev. Respir. Dis. 132:180 182. NHLI (National Heart and Lung Institute). 1973. Work- shop on screening programs for early diagnosis of airway obstruction. October. Bethesda, Md.: National Heart and Lund Institute, Division of Lung Diseases. Niederman, M. S., T. D. Rafferty, C. T. Sasaki, W. W. Merrill, R. A. Matthay, and H. Y. Reynolds. 1983. Comparison of bacterial adherence to cilated and squamous epithelial cells obtained from the human respiratory tract. Am. Rev. Respir. Dis. 127:85-90. NilUforov, A. I., and R B. Schlesinger. 1985. Morphome- tric variability of the human upper bronchial tree. Respir. Physiol. 59:289-299. Nolop, K. B., D. L. Maxwell, D. Royston, and J. M. Hughes. 1986. Effect of raised thoracic pressure and volume on 99 - c-DTPA clearance in humans. J. Appl. Physiol. 60:1493-1497. Norman, P. S. 1980. Skin testing, pp. 789 - 793. In N. R. Rose and H. Friedman, Eds. Manual of Clinical Immunology, 2d ed. Washington, D.C.: American Society for Microbiology. Normand, I. C. S., R. E. Oliver, E. O. R. Reynolds, and L. B. Strang. 1971. Permeability of lung capillaries and alveoli to non-electrolytes in foetal lamb. J. Physiol. 219:303 - 330. NRC National Research Council. 1987. Phannacokine- tics in Rick Ass~nent. Doing Water and Health, Vol.8. Washington,D.C.: NationalAcademy Press. 488 pp. NRC National Research Council. 1989. Dreg Water and Health, Vol. 9. Washington, D.C.: National Academy Press. NTP(NationalTo~cologyProgram). 1986. Toxicology and Carcinogenesis Studies of Benzene in F344/N Rats and B6C3F~ Mice (Gavage Studies3. NTP TR 289. Research Triangle Park,N.C.: U.S.Department of Health and Human Services. 277 pp. Nugent, K. M., J. Glazier, J., M. M. Monick, and G. W.

156 Hunninghake. 1985. Stimulated human alveolar macrophages secrete interferon. Am. Rev. Respir. Dis. 131:714 - 718. O'Byrne, P. M. 1986. Airway inflammation and airway hyperresponsiveness. Chest 90:575 - 577. O'Byrne, P. M., M. Dolovich, R. Dirks, R. S. Roberts, andM.T. Newhouse. 1984. Lung epithelialpe~mea- bility: Relation to nonspecific airway responsiveness. J. Appl. Physiol. 57:77 - 84. Oberdorster, G., and A. P. Freedman. 1981. Lung clearance measurements in rats using magnetopneumo- graphy, pp. 19 - 24. In W. Stober, and D. Hochrainer, Eds. Aerosols in Science, Medicine and Technology, Vol. 9. Schmallenberg, F.R.G.: Gesellschaft fur Aerosolforschung. Oberdorster, G., M. J. Utell, P. E. Morrow, R. W. Hyde, and D. A. Weber. 1986. Bronchial and alveolar absorption of inhaled 99mrc-DTPA. Am. Rev. Respir. Dis. 134:944 - 950. Ogilvie, C. M., R. E. Forster, W. S. Blakemore, and J. W. Morton. 1957. A standardized breath holding technique for the clinical measurement of the diffusing capacity of the lung for carbon monoxide. J. Clin. Invest. 36:1 - 17. Ogra, P. L., J. C. Cumella, and R. C. Welliver. 1984. Immune response to viruses, pp. 242 - 263. In J. Bien- enstock, Ed. Immunology of the Lung and Upper Respiratory Tract. New York: McGraw-Hill. Ohyama, S., T. Inamasu, M. Ishizawa, N. Ishinishi, and K. Matsuura. 1987. Mutagenicity of human urine after the consumption of fried salted salmon. Food Chem. Toxicol. 25:147 - 153. Osterman-Golkar, S., L. Ehrenberg, D. Segerback, and I. Hallstrom. 1976. Evaluation of genetic risks of alkylating agents. II. Haemoglobin as a dose monitor. Mutat. Res. 34:1 - 10. Osterman-Golkar, S., P. B. Farmer, D. Segerback, E. Bailey, C. J. Calleman, K Svensson, and L. Ehrenberg. 1983. Dosimetry of ethylene oxide in the rat by quan- titation of alkylated histidine in hemoglobin. Terato- genesis Carcinog. Mutagen. 3:395 - 405. Otis, A. B., C. B. McKerrow, R. A. Bartlett, J. Mead, M. B. McIlroy, N. J. Selverstone, and E. P. Radford. 1956. Mechanical factors in distnbution of pulmonary ventilation. J. Appl. Physiol. 8:427 - 443. Overland, E. S., R. N. Gupta, G. J. Huchon, and J. F. Murray. 1981. Measurement of pulmonary tissue volume and blood flow in persons with normal and edematous lungs. J. Appl. Physiol. 51:1375 - 1383. Pacht, E. R., H. Kaseki, J. R. Mohammed, D. G. Corn- well, and W. B. Davis. 1986. Deficiency of vitamin E in the alveolar fluid of cigarette smokers. Influence on alveolar macrophage cytotoxicity. J. Clin. Invest. 77:789 - 796. Palmes, E. D., B. Altshuler, and N. Nelson. 1967. Depo- sition of aerosols in the human respiratory tract curing breath holding, pp.339 - 347. In C. N. Davies, Ed. Inhaled Particles and Vapours II. Oxford: Pergamon. REFERENCES Palmes, E. D., R. M. Goldr~g0 C. S. Wang, and B. Altshu- ler. 1971. Effect of chronic obstructive pulmonary disease on rate of deposition of aerosols in the lung during breath holding, pp.123 130. In W. H. Walton, Ed. Inhaled Particles III. Surry: Unwin. Palmes, E. D., C. S. Wang, R. M. Goldring, and B. Altshu- ler. 1973. Effect of depth of inhalation on aerosol persistence during breath holding. J. Appl. Physiol. 34:356 - 360. Paradis, I. L., J. H. Dauber, and B. S. Rabin. 1986. Lymphocyte phenotypes in bronchoalveolar ravage and lung tissue in sarcoidosis and idiopathic pulmonary fibrosis. Am. Rev. Respir. Dis. 133:855 - 860. Patterson, D. G., R. E. Hoffman, L. L. Needham, D. W. Roberts, J. R. Bagby, J. L. Pirkle, H. Falk, E. J. Sampson, and V. N. Houk. 1986. 2,3,7,8-Tetra- chlorodibenzop-diox~n levels in adipose tissue of exposed and control persons in Missouri: An interim report. J. Am. Med. Assoc. 256:2683 - 2686. Patton, S. E., L. B. Gilmore, A. M. Jetten, P. Nettesheim, and G. E. Hook. 1986. Biosynthesis and release of proteins by isolated pulmonaIy aara cells. Exp. Lung Res. 11:277 - 294. Penn, I. 1978. Development of cancer in transplantation patients. Adv. Surg. 12:155 - 191. Pepys, J., and B. J. Hutchcroft. 1975. Bronchial provoca- tion tests in etiologic diagnosis and analysis of asthma. Am. Rev. Respir. Dis. 112:829 - 859. Pereira, M. A., and L. W. Chang. 1981. Binding of chemical carcinogens and mutagens to rat hemoglobin. Chem.-Biol. Interact. 33:301 - 305. Pereira, M. A., F. J. Burns, and R. E. Albert. 1979. Dose response for benzo~a~pyrene adducts in mouse epidermal DNA. Cancer Res. 39:2556 - 2559. Perera, F. P., and I. B. Weinstein. 1982. Molecular epidemiology and carcinogen-DNA adduct detecdon: New approaches to studies of human cancer causation. J. Chronic Dis. 35:581 - 600. Perez, H. D. 1984. Biologically active complement (C5~-derivedpeptides and their relevance to disease. CRC Crit. Rev. Oncol. Hematol. 1:199 - 225. Perkett, E. A., K. L. Brigham, and B. Meyrick. 1988. Granulocyte depletion (PMN) attenuates chronic pulmonary hypertension following pulmonary air embolization. Fed. Am. Soc. Exp. Bio. J. 2:A1579. (Abstract.) Peslin, R., and J. J. Fredberg. 1986. Oscillation mecha- nics of the respiratory system, pp. 145 - 177. In P. T. Macldem and J. Mead, Eds. Handbook of Physiol- o$y, Section 3: The Respiratory System. Volume III. Mechanics of Breathing, Part 1. Bethesda, Md.: American Physiological Society. Peslin, R., C. Gallina, and C. DuvMer. 1986. Respiratory transfer impedances with pressure input at the mouth and chest. J. Appl. Physiol. 61:81 - 86. Peterson, B. T., and L. D. Gray. 1987. Pulmonary lym- phatic clearance of 99mTc-DTPA from the air spaces during lung inflation and lung inju~y. J. Appl. Physiol. 63:1136 - 1141.

REFERENCES Peterson, B. T., H. L. James, and J. W. McLarty. 1986. Effects of lung volume on the compartmental analysis of alveolar solute clearance in sheep. Physiologist 29:172. (Abstract.) Peterson, B. T., H. L. James, and J. W. McLarty. 1988. Effects of lung volume on clearance of solutes from the air spaces of lungs. J. Appl. Physiol.64:1068 1075. Peterson, B. T., J. D. Dickerson, H. L. James, E. J. Miller, J. W. McCarty, and D. B. Holiday. 1989. Comparison of three tracers for detecting lung epithelial injury in anesthetized sheep. J. Appl. Physiol.66:2374 - 2383. Peto, R., F. E. Speizer, A. L. Cochrane, F. Moore, C. M. Fletcher, C. M. Tinker, I. T. T. Higgins, R. G. Gray, S. M. Richards, J. Gilliland, and B. Norman-Smith. 1983. The relevance in adults of air-flow obstruction, but not of mucus hypersecretion, to mortality from chronic lung disease. Am. Rev. Respir. Dis. 128:491 - 500. Petty, T. L., G. W. Silvers, R. E. Stanford, M. D. Baird, and R. S. Mitchell. 1980. Small airway pathology is related to increased closing capacity and abnormal slope of phase III in excised human lungs. Am. Rev. Respir. Dis. 121:449 - 456. Phalen, R. F., R. C. Mannix, and R. T. Drew. 1984. Inhalation exposure methodology. Environ. Health Perspect. 56:23 - 34. Pickrell, J. A. 1981. Collagen degradation, pp. 61 - 70. In Lung Connective Tissue: Location, Metabolism and Response to Injury. Boca Raton, Fla.: CRC Press. Pickrell, J. A., R. E. Gregory, D. J. Cole, F. F. Hahn, and R. F. Henderson. 1987. Effect of acute ozone exposure on the proteinase-antiproteinase balance in the rat lung. Exp. Mol. Pathol. 46:168 179. Pinkston, P., P. B. Bitterman, and R. G. Crystal. 1983. Spontaneous release of interleukin-2 by lung T lym- phocytes in active pulmonary sarcoidosis. N. Engl. J. Med. 308:793 - 800. Pinkston, P., P. Bitterman, A. Hance, S. Douches, S. Goodman, and R. Crystal. 1984. In vivo demonstra- tion of the importance of interleukin-2 in the prolifera- tion of human T-lymphocytes. Clin. Res. 32:355A. (Abstract.) Pirastu, M., Y. W. Kan, A. Cao, B. J. Conner, R. L. Teplitz, and R. B. Wallace. 1983. Prenatal diagnosis of beta-thalassemia: Detection of a single nucleotide mutation in DNA. N. Engl. J. Med. 309:2~287. Pistolesi, M., and C. Guintini. 1978. Assessment of extravascular lung water. Radiol. Clin. North Am. 16:551 - 574. Poirier, M. C., and F. A. Beland. 1987a. Determination of carcinogen-induced macromolecular adducts in animals and humans. Prog. Exp. Tumor Res.31:1 - 10. Poirier, M. C., and F. A. Beland, Eds. 1987b. Carcino- genesis and Adducts in Animals and Humans. Pro- ceedings of the Workshop on Carcinogenesis and Adducts in Humans and Animals, Cambridge, Mass., Feb.25, 1986. Progress in Experimental Tumor Re- search, Vol. 31. Basel: Karger. 117 pp. 157 Poirier, M. C., E. Reed, R. F. Ozols, T. Fasy, and S. H. Yuspa. 1987. DNA adducts of cisplatin in nu- cleated peripheral blood cells and tissues of cancer patients. Prog. Exp. Tumor Res. 31:104 - 113. Powell, K. R., R. Shorr, J. D. Cherry, and J. O. Hendley. 1977. Impraved method for collection of naca1 mucus. J. Infect. Dis. 136:109 - 111. Prochownik, E. V., S. Antonarakis, K A. Bauer, R. D. Rosenberg, E. R. Fearon, and S. H. Orkin. 1983. Molecular heterogeneity of inherited antithrombin III deficiency. N. Engl. J. Med. 308:1549 - 1552. Proctor, D. F. 1979. Tests of anway defense mechani~ns, pp.227 - 241. InP. E.Macklem andS. Permutt, Eds. The Lung in the Transition Between Health and Disease. Lung Biology in Health and Disease, Vol. 12. New York: Marcel Dekker. Proctor, D. F. 1982. The upper airway, pp. 23 - 44. In D. F. Proctor and I. Andersen, Eds. The Nose: Upper Akway Physiology and the Atmospheric Environment. New York: Elsevier. Proctor, D. F., I. B. Andersen, and G. LundcIvist. 1977. Nasal mucociliary function in humans, pp.427 - 452. In J. D. Brain, D. F. Proctor and L. M. Reid, Eds. Respiratory Defense Mechanisms, Part 1. Lung Biol- og;y in Health and Disease, Vol. 5, Pt. 1. New York: Marcel Dekker. Puchelle, E., F. Aug. J. M. Zahm, and A. B~and. 1982 Comparison of nasal and bronchial mucocilia~y clear- ance in young non-smokers. Clin. Sci. 62:13 - 16. Quinlan, M. F., S. D. Salman, D. L. Swift, H. N. Wagner, Jr., and D. F. Proctor. 1969. Measurement of mucoc0- iasy function in man. Am. Rev. Respir. Dis.99:13 ~. Rabinovitch, M., W. J. Gamble, O. S. Miettinen, and L. Reid. 1979. Age and sex influence on pulmonary hypertension of chronic hypoxia and on recovery. Am. J. Physiol. 240:H62-H72. Rabinovitch, M., J. F. Keane, K. E. Fellows, A. R. Ca~ taneda, and L. Reid. 1981. Quantitative analysis of the pulmonary wedge an~ogram in congenital heart defects. Correlation with hemodynamic data and morphometric findin{~ in lung biopsy tissue. Circula- tion 63:152 - 164. Rabinovitch, M., J. F. Kean, W. I. Norwood, A. R. Ca~ taneda, and L. Reid. 1984. Vascular structure in lung tissue obtained at biopsy correlated with pul- monary hemo~ynamic findin~ after repair of congeni- tal heart defects. Circulation 69:655 - 657. Ramanna, L., D. P. Tashkin, G. V. Taplin, D. Elam, R. Detels, A. Coulson, and S. N. Rokaw. 1975. Radioaerosol lung imaging in chronic obstructive pulmonary disease: Comparison with pulmonary function tests and roentgenography. Chest 68:~640. Ramsey, J. C., and M. E. Andersen. 1984. Aphysiologi- callybased description of theinhalationpharmacokine- tics of styrene in rats and humans. Toxicol. Appl. Pharmacol. 73:159 - 175. Ramsey, J. C., J. D. Young, R. Karbowski, M. B. Cheno- weth, L. P. McCarty, and W. H. Braun. 1980. Phar- macokinetics of ir~haled styrene in human volunteers.

158 Toxicol. Appl. Pharmacol. 53:54 - 63. Randerath, K, E. Randerath, H. P. Agrawal, R. C. Gupta, M. E. Schurdak and M. V. Reddy. 1985. Postlabelir~g methods of carcinogen-DNA adduct analysis. Environ. Health Perspect. 62:57 - 65. Ranga, V., J. Kleinerman, M. P. C. Ip, and A. M. Collins. 1980. The effect of nitrogen dioxide on tracheal uptake and transport of horseradish peroxidase in the guinea pig. Am. Rev. Respir. Dis. 122:483 - 490. Rankin, J. A., P. E. Synder, E. N. Schachter, and R. A. Matthay. 1984. Bronchoalveolarlavage: Its safety in subjects with mild asthma. Chest 85:723 - 728. Rao, A., S. B. Mizel, and H. Cantor. 1983. Disparate functional properties of two interleukin 1-responsive Ly-1 +2-T cell clones: Distinction of T cell growth factor and T cell-replacing factor activities. J. Im- munol. 130:1743 - 1748. Razin, A., and A. D. Riggs. 1980. DNA methylation and gene function. Science 210:604 - 610. Rearick, J., and A. M. Jetten. 1986. Accumulation of cholesterol 3-sulfate during in vitn' squamous differen- tiation of rabbit tracheal epithelial cells and its regula- tion by retinoids. J. Biol. Chem. 261:13898 - 13904. Rearick J. I., M. Deas, and A. M. Jetten. 1987. Synthesis of mucous glycoproteins by rabbit tracheal cells in vitn': Modulation by substratum, retinoids and cyclic AMP. Biochem. J. 242:19 - 25. Reasor, M. J., D. Nadeau, and G. E. R. Hook. 1978. Extracellular alkaline phosphatase in the airways of the rabbit lung. Lung 155:321 - 325. Reddy, E. P., R. K Reynolds, E. Santos, and M. Barbacid. 1982. A point mutation is responsible for the acquisi- tion of transforming properties by the T24 bladder carcinoma oncogene. Nature 300:149 - 152. Regal, J. F. 1988. Role of arachidonate metabolites in CSa-induced bronchoconstriction. J. Pharmacol. Exp. Ther. 246:542 - 547. Reid, K. B., and E. Solomon. 1977. Biosynthesis of the first component of complement by human fibroblasts. Biochem. J. 167:647 - 660. Reid, L. M. 1979. The pulmonary circulation: Remodel- ing in growth and disease. Am. Rev. Respir. Dis. 119:531 - 546. Reitz, R. H., T. R. Fox, and P. G. Watanabe. 1986. The role of pharmacokinetics in risk assessment. Basic Life Sci. 38:499 - 507. Remington, J. S., K. L. Vosti, A. Lietze, et al. 1964. Serum proteins and antibody activity in human nasal secretions. J. Clin. Invest. 43:1613 - 1624. Rennard, S. I., and R. G. Crystal. 1982. Fibronectin in human bronchopulmonary ravage fluid. Elevation in patients with interstitial lung disease. J. Clin. Invest. 69:113 - 22. Rennard, S. I., G. Basset, D. Lecossier, K M. O'Donnell, P. Pinkston, P. G. Martin, and R. G. Crystal. 1986. Estimation of absolute volume of epithelial lining fluid recovered by ravage using urea as a marker of dilution. J. Appl. Physiol. 60:532 - 538. Reynolds, H. Y. 1979. Lung host defenses: A status REFERENCES report. Chest 75(Suppl. 2~:239 - 242. Reynolds, H. Y. 1987. Bronchoalveolar ravage. Am. Rev. Respir. Dis. 135:250 - 263. Reynolds, H. Y., and W. W. Merrill. 1981. Pulmonary immunology: Humoral and cellular immune re- sponsiveness of the respiratory tract, pp. 381 - 422. In D. H. Simmons, Ed. Current Pulmonology, Vol. 3. New York: John Wiley & Sons. Reynolds, H. Y., and H. H. Newball. 1974. Analysis of proteins and respiratory cells obtained from human lungs by bronchial ravage. J. Lab. Clin. Med. 84:559 - 573. Reynolds, H. Y., J. A. Ka~ erow~, and H. H. Newball. 1975. Specif~city of opsonic antibodies to enhance phagocytosis of Pseudomonas aen~g`nosa by human alveolar macrophages. J. Clin. Invest. 56:376 - 385. Reynolds, H. Y., J. D. Fulmer, J. A. Kazmierowski, W. C. Roberts, M. M. Frank, and R. G. Crystal. 1977. Analysis of cellular and protein content of broncho-al- veolar ravage fluid from patients with idiopathic pul- monary fibrosis and chronic hyp~sensitivity pneumoni- tis. J. Clin. Invest. 59:165 - 175. Rhodes, C. G., P. Wollmer, F. Fazio, and T. Jones. 1981. Quantitative measurement of regional extravascular lung density using positron emission and transmission tomography. J. Comput.Assist.Tomogr.5:783 - 791. Richter, A. M., R. T. Abboud, and S. S. Johal. 1986. Methylene blue decreases the functional activity of alpha-l-pro/ease inhibitor in bronchoalveolar ravage. Am. Rev. Respir. Dis. 134:326 - 327. Rinderknecht, J., L. Shapiro, M. Krauthammer, G. Taplin, K. Wasserman, J. M. Uszler, and R. M. Effros. 1980. Accelerated clearance of small solutes from the lungs in interstitial lung disease. Am. Rev. Respir. Dis. 121:105 - 117. Rikk, N. W., J. M. Luce, J. M. Hoeffel, D. C. Price, and J. F. Murray. 1984. Site of deposition and factors affecting clearance of aerosolized solute from canine lungs. J. Appl. Physiol. 56:723 - 729. Robbins, R. A., J. E. Gadek, and R. G. Crystal. 1981. Potential role of the complement system in propagating the alveolitis of idiopathic pulmonary fibrosis. Am. Rev. Respir. Dis. 123~4 Pt. 2~:50. (Abstract.) Roberts, J. A., I. W. Rodger, and N. C. Thomson. 1985. AiMray responsiveness to histamine in men: Effect of atropine on invivo and in vitro compaIison. Thorax 40:261 - 267. Robertson, J., J. R. Caldwell, J. R. Castle, and R. H. Waldman. 1976. Evidence for the presence of com- ponents of the alternative (properdin) pathway ol complement activation in respiratory secretions. J. Immunol. 117:900 903. Robins, R. A., J. E. Gadek, S. I. Rennard, Y. F. Chen, and R. G. Crystal. 1982. Compartmentalization of the complement system: The normal lung is C5 "de- ficient." Am. Rev. Respir. Dis. 125:53. (Abstract.) Robinson, B. W., T. L. McLemore, and R. G. Crystal. 1985. Gamma interferon is spontaneously released by alveolar macrophages and lung T lymphocytes in

REFERENCES patients with pulmonary sarcoidosis. J. Clin. Invest. 75:1488 - 1495. Robinson, S. E., and A. P. Freedman. 1979. Direct magnetopneumographic measurement of particle concentrations and clearance in the lung, pp.183 - 188. In Institute of Electrical and Electronics Engineers, Engineering in Medicine and Biology Society. Fron- tiers of Engineering in Health Care. New York: Institute of Electrical and Electronics Engineers. Rodarte, J. R., and K. Rehder. 1986. Dynamics of respiration, pp. 131 - 144. In P. T. Macklem and J. Mead, Eds. Handbook of Physiology, Section 3: The Respiratory System. Volume III. Mechanics of Breathing,Partl. Bethesda,Md.: AmericanPhysio- logical Society. Rog~i, V. L., and A. R. Brody. 1984. Changes in num- bers and dimensions of chrysotile asbestos fibers in lungs of rats following short-term exposure. Exp. Lung Res. 7:133 - 147. Roggli, V. L., C. A. Piantadosi, and D. Y. Bell. 1986. Asbestos bodies in bronchoalveolar ravage fluid: A study of 20 asbestos-exposed individuals and com- parison to patients with other chronic interstitial lung diseases. Acta Cytol. 30:470 - 476. Rogg i, V. L., M. George, and A. R. Brody. 1987. Clear- ance and dimensional changes of crocidolite asbestos fibers isolated from lungs of rats following short-term exposure. Environ. Res. 42:94 - 105. Rom, W. N., J. E. Lockey, K. M. Bang, C. Dewitt, and R E. Johns, Jr. 1983. Reversible beryllium sensitiza- tion in a prospective study of beryllium workers. Arch. Environ. Health 38:302 - 307. Roop, D. R., J. L. Nordstrom, S. Y. Tsai, M. J. Tsai, and B. W. O'Malley. 1978. Transcription of structural and intervening sequences in the ovalbumin gene and id~fication of potential avalbumin mRNA precursom Cell 15:671 - 685. Rossen, R. D., R. H. Alford, W. T. Butler, and W. E. Vannier. 1966. The separation and characterization of proteins intrinsic to nasal secretion. J. Immunol. 97:369-378. Rossen, R. D., J. A. Kasel, and R. B. Couch. 1971. The secretory immune system: Its relation to respiratory viral infection. Prog. Med. Virol. 13:194 - 238. Rossi, G. A., G. B. Di Negro, E. Balzano, E. Cerri, O. Sacco, B. Balbi, A. Venturini, R. Ramoino, and C. Ravazzoni. 1985. Suppression of the alveolitis of pulmonary sarcoidosis by oral corticosteroids. Lung 163:83 - 93. Rossman, C. M., R. M. K. W. Lee, J. B. Forrest, and M. T. Newhouse. 1984. Nasal ciliary ultrastructure and function in patients with prima~y cilia~y dy~inesia compared with that in normal subjects and in subjects with various respiratory diseases. Am. Rev. Respir. Dis. 129:161 - 167. Rossman, M. D., J. H. Dauber, and R. P. Daniele. 1978. Identification of activatedT cellsin sarcoidosis. Am. Rev. Respir. Dis. 117:713 - 720. Roth, R.A. 1985. Biochemistry, physiology end drug 159 metabolism: Implications regarding the role of the lungs in drug disposition. Clin. Physiol. Biochem. 3:66 79. Sabourin, P. J., B. T. Chen, G. Lucier, L. S. Birnbaum, E. Fisher, and R. F. Henderson. 1987a. Effect of dose on the absorption and excretion of [~4C]benzene administered orally or by inhalation in rats and mice. Toxicol. Appl. Pharmacol. 87:325 - 336. Sabourin, P. J., W. Bechtold, L. Birnbaum, G. Lucier, and R. Henderson. 1987b. Water-soluble benzene metabolites in F344/N rats and B6C3F' mice during and following 3H-benzene inhalation. Toxicolog~st 7:232. Sabourin, P. J., W. E. Bechtold, L. S. Birnbaum, G. Lucier, and R. F. Henderson. 1988. Differences in the metabolism and disposition of inhaled [3H]benzene by F344/N rats and B6C3F1 mice. Toxicol. Appl. Pharmacol. 94:128 - 140. Sackner, SI. A., A. Wanner, and J. Landa. 1972. Applica- tions of bronchofiberosoopy. Chest 62(SuppL):S7~S78. Sackner, M. A., M. J. Rosen, and A. Wanner. 1973. Eshmation of tracheal mucous velocky by bronchofiber- scopy. J. Appl. Physiol. 34:495 - 499. Sackner, M. A., D. Ford, R. Fernandez, J. Cipley, D. Perez, M. Kwoka, M. Reinhart, E. D. Michaelson, R. Schreck, and A. Wanner. 1978. Effects of sulfuric acid aerosol on cardiopulmonary function of dogs, sheep, and humans. Am. Rev. Respir. Dis. 118:497 - 510. Said, S. I. 1982. Pulmonary metabolism of prostaglandins and vasoactive peptides. Annul Rev. Physiol. 44:257 - 268. Saksella, K., J. Bergh, V. P. Lehto, K. Nilsson, and K. Alitalo. 1985. Amplif~cation of the c~nyc oncogene in a subpopulation of human small cell lung cancer. Cancer Res. 45:1823 - 1827. Saltini, C., A. J. Hance, V. J. Ferrans, F. Basset, P. B. Bitterman, and R. G. Crystal. 1984. Accurate quan- tification of cells recovered by bronchoalveolar ravage. Am. Rev. Respir. Dis. 130:650 - 658. Saltini, C., J. R. Spurzem, J. J. Lee, P. Pinkston, and R. G. Crystal. 1986. Spontaneous release of inter- leukin 2 by lung T-lymphocytes in active pulmonary sarcoidosis is primarily from the Leu3+DR~ T cell subset. J. Clin. Invest. 77:1962 - 1970. Samet, J. M. 1978. A historical and epidemiologic per- spective on respiratory symptoms questionnaires. Am. J. Epidemiol. 108:435 - 446. Samet, J. M., I. B. Tager, and F. E. Speizer. 1983. The relationship between respiratory illness in childhood and chronic air-flow obstruction in adulthood. Am. Rev. Respir. Dis. 127:508 - 523. Sanchis, J., M. Dolovich, R. Chalmers, and M. Newhouse. 1972. Quantitation of regional aerosol clearance in the normal human lung. J. Appl. Physiol. 33:757 - 762. Santa Cruz, R., J. Landa, J. Hirsch, and M. A. Sackner. 1974. Tracheal mucous velocity in normal man and patients with obstructive lung disease: Effects of terbutaline. Am. Rev. Respir. Dis. 109:458 - 463.

160 Santella, R. M., F. Gasparo, and L. L. Hsieh. 1987. Quantitation of carcinogen-DNA adducts with mono- clonal antibodies. Prog. Exp. Tumor Res.31:63 - 75. Santos, E., D. Martin-Zanca, E. P. Reddy, M. A. Pierotti G. Della Porta, and M. Barbacid. 1984. Malignant activation of a K-ras oncogene in lung carcinoma but not in normal tissue of the same patient. Science 223:661 - 664. Sasame, H. A., and M. R. Boyd. 1979. Superoxide and hydrogen peroxide production and NADPH oxidation stimulated by nitrofurantoin in lung microsomes: Possible implications for toxicity. Life Sci. 24:1091 - 1096. Schecter, A., T. Tiernan, F. Schaffner, M. Taylor, G. Gitlitz, G. F. VanNess, J. H. Garrett, and D. J. Wagel. 1985. Patient fat biopsies for chemical analysis and liver biopsies for ultrastructural characterization after exposure to polychlorinated dioxins, furans, and PCBs. Environ. Health Perspect. 60:241-254. Schleimer, R. P., D. W. MacGlashan, Jr., S. P. Peters, N. Naclerio, D. Proud, N. F. Adkinson, Jr., and L. M. Lichtenstein. 1984. Inflammatory mediators and mechanisms of release from purif~ed human basophils and mast cells. J. Allergy Clin. Immunol. 74:473081. Schlesinger, R. B. 1989. Deposition and clearance of inhaled particles, pp. 163 - 192. In R. O. McClellan and R. F. Henderson, Eds. Concepts in Inhalation Toxicology. Washington, D.C.: Hemisphere. Schles nger, R. B., and K E. Driscoll. 1988. Respiratory tract defense mechanisms and their interaction with air pollutants, pp. 37 - 72. In M. A. Hollinger, Ed. Focus on Pulmonary Pharmacology and Toxicology. Boca Raton, Fla.: CRC Press. Schlesinger, R B., M. Lippmann, and R. E. Albert. 1978. Effects of short-term exposures to sulfuric acid and ammonium sulfate aerosols upon bronchial airway function in the donkey. Am. Ind. Hyg. Assoc. J. 39:275 - 286. Schlesinger, R. B., M. Halpern, R. E. Albert, and M. Lippmann. 1979. Effect of chronic inhalation of sulfuric acid mist upon mucociliary clearance from the lungs of donkeys. J. Environ. Pathol. Toxicol. 2:1351 - 1367. Schlesinger, R. B., M. Halpern, and M. Lippmann. 1982. Long~term clearance of inhaled magnetite and poly- styrene latex from the lung: A comparison. Health Phys. 42:68 - 73. Schlesinger, R. B., B. Naumann, and L. C. Chen. 1983. Physiological and histological alterations in the bron- chial mucodliary clearance system of rabbits following intermittent oral or nasal inhalation of sulfuric acid mist. J. Toxicol. Environ. Health 12:441 - 465. Schlesinger, R. B., T. A. Vollmuth, B. D. Naumann, and K. E. Driscoll. 1986. Measurement of particle clear- ance from the alveolar region of the rabbit respiratory tract. Fundam. Appl. Toxicol. 7:25~263. Schmidt, J. A., S. B. Mizel, D. Cohen, and I. Green. 1982. Interleulcin 1, a potential regulator of fibroblast proliferation. J. Immunol. 128:2177 - 2182. REFERENCES Schober, O., G. J. Meyer, C. Bossaller, P. Lobenhoffer, B. Knoop, S. Muller, H. Creutz g, J. Sturm, P. Lichtlen, and H. Hundeshagen. 1983. Quantitative measure- ments of regional extravascular lung water in dogs using positron emission tomography. ROEFO 139:117 - 126. (In German.) Schulman, E. S. 1986. The role of mast cell derived mediators in airway hyper-responsiveness. Chest 90:578 - 583. Schulman E. S., and C. L. Anderson. 1985. Lung hyper- sensitivity responses: Dissociation of human lung mast cell leukotriene C4 (LTC4) from histamine re- lease. Prog. Clin. Biol. Res. 199:209 - 220. Schulman, E., M. Liu, D. Proud, D. Macglashan, Jr., L. Lichtenstein, end M. Plaut. 1985. Human lung macrophages induce histamine release from basophils and mast cells. Am. Rev. Respir. Dis. 131:230 - 235. Schuster, D. P., M. A. Mintun, M. A. Green, and M. M. Ter-Pogossian. 1985. Regional lung water and hematocrit determined by positron emission tomo- graphy. J. Appl. Physiol. 59:860868. Schuster, D. P., G. F. Marklin, end M. A. Mintun. 1986. Regional changes in ~avas~lar lung water detected by positron emission tomography. J. Appl. Physiol. 60:11701178. Schuyler, M. R. T. P. ll~n, and J. E. Sah~io. 1978. Lom1 pulmonary immunity in pigeon breeder's disease: A case stud~r. Ann. Intern. Med. 88:355 - 358. Schwartz, L. B., and K. F. Austen. 1984. Structure and function of the chemical mediators of mast cells. Prog. Allergy 34:271 - 321. Schwartz, L. B., M. S. Kawahara, T. E. Hugli, D. Vik, D. T. Fearon, and K. F. Austen. 1983. Generation of C3a anaph~rlato'an from human C3 l~y human mast cell tryptase. J. Immunol. 130:1891 - 1895. Seaton, A. 1983. Coal and the lung. Thorax 38:241 - 243. Sega, G. A., R. P. Valdivia Alcota, C. P. Tanconge, and P. A. Brimer. In press. Acrylamide binding to the DNA and protamine of spermigenic stages in the mouse and its relationship to genetic damage. Mutat Res. Segerback D. 1983. Alkylation of DNA and hemoglobin in the mouse following eyposure to ethene and ethene oxide. Chem. Biol. Interact. 45:139 - 151. Seldcoff, I. J., and E. C. Hammond. 1978. Asbestos-asso ciated disease in United States shipyards. CA 28:87 - 99. Seltzer, J., B. G. Bigby, M. Stulbarg, M. J. Holtzman, J. A. Nadel, I. F. Ueki, G. D. Leikauf, E. J. Goetzl, and H. A. Boushey. 1986. O3-induced change in bronchial reac~vity to methacholine and anw~r inflam- mation in humans. J. Appl. Physiol. 60:1321 - 1326. Semenzato, G., A. Pezzutto, M. Chilosi, and G. Pizzolo. 1982. Redistnbution of T lymphocytes in the lymph nodes of patients with sarcoidosis. N. Engl. J. Med. 306:48 - 49. Sharma, R. P., Ed. 1981. Immunologic Considerations in toxicology. BocaRaton,Fla.: CRC Press. 2vols. Sheppard,D. 1986a Mechanisms ofbronchoconstriction

REFERENCES from nonimmunologic environmental stimuli. Chest 90:584 - 587. Sheppard, D. 1986b. Significance of anway hyperrespon- siveness to occupational and environmental lung disorders. Semin. Respir. Med. 7:241 - 248. Sheppard, D., W. S. Wong, C. F. Uehara, J. A. Nadel, and H. A. Boushey. 1980. Lower threshold and greater bronchomotor responsiveness of asthmatic subjects to sulfur dioxide. Am. Rev. Respir. Dis. 122:873 - 878. She, F., S. Kudoh, A. Shibuya, K Sada, and R. Mikami. 1981. Crackles in asbestos workers: Auscultation and lung sound analysis. Br. J. Dis. Chest 75:386 396. Shu, H., R. E. Talcott, S. A. Rice, and E. T. Wei. 1979. Lipid peroxidation and paraquat toxicity. Biochem. Pharmacol. 28:327 - 331. Shugart, L., and R. Matsunami. 1985. Adduct formation in hemoglobin of the newborn mouse exposed in utero to benzotaipyrene. Toxicology 37:241 - 245. Sibbald, W. J., F. J. Warshawski, A. K. Short, J. Harris, M. S. Lefcoe, and R. L. Holliday. 1983. Clinical studies of measuring extravascular lung water by the thermal dye technique in critically ill patients. Chest 83:725 - 731. Sietsema, K., R. M. Effros, S. T. Siu, and G. R. Mason. 1986. Solute concentrations of bronchoalveolar fluid. Am. Rev. Respir. Dis. 133:A20. (Abstract.) Simani, A. S., S. Inoue, and J. C. Hogg. 1974. Penetra- tion of the respiratory epithelium of guinea pigs follow- ing exposure to cigarette smoke. Lab. Invest.31:75 - 81. Simenhoff, M. L., J. F. Burke, J. J. Saukkonen, A. Or- dinar'n and R Dotv. 1977. Biochemical orofile , _ _ , of uremic breath. N. Engl. J. Med. 297:132 - 135. Sivak, E. D., and H. P. Wiedemann. 1986. Clinical measurement of extravascular lungwater. Crit. Care Clinics 2:511 - 526. Slauson, D. O. 1982. The mediation of pulmonary inflammatory injury. Adv. Vet. Sci. Comp. Med. 26:99 - 153. Small, P., D. Barrett, S. Frenkiel, L. Rochon, C. Cohen, and M. Black. 1985. Measurement of antigen-specific IgE in nasal secretions of patients with perennial rhinitis. Ann. Allergy 55:68 - 71. Smits, H. L., and A. M. Jetten. In press. Molecular cloning of gene sequences regulated during squamous differentiation of tracheal epithelial cells and controlled by retinoids. J. Biol. Chem. Snider, D. E., Jr. 1982. The tuberculin skin test. Am. Rev. Respir. Dis. 125:S108-S118. Snipes, M. B., B. A. Muggenburg, and D. E. Bice. 1983. Translocation of particles from lung lobes or the peritoneal cavity to regional lymph nodes in bea~e dogs. J. Toxicol. Environ. Health 11:703 - 712. Snyder, A., L. Skoza, and Y. Kikkawa. 1983. Compara- tive removal of ascorbic acid and other airway sub- stancesby sequentialbronchoalveolar ravages. Lung 161:111 - 121. Snyderman, R. 1981. Chemotaxis of human and murine mononuclear phagocytes, pp. 535 - 547. In D. O. 161 Adams, P. J. Edelson, and H. S. Koren, Eds. Methods for Studying Mononuclear Phagocytes. New York: Academic Press. Soter, N. A., R. A. Lewis, E. J. Corey, and K F. Austen. 1983. Local effects of synthetic leukotrienes (LTC4, LTD4, LTE4, and LTB4) in human skin. J. Invest. Dermatol. 80:115 - 119. Speizer, F. E., and I. B. Tager. 1979. Epidemiology of chronic mucus hypersecretion and obstructive ain~rays disease. Epidmiol Rev 1:124 - 142. Spektor, D. M., M. Lippmann, P. J. Licy, G. D. Thurston, K. C*ak, D. J. James, N. Bock, F. E. Speizer, and C. Hayes. 1988. Effects of ambient ozone on respira- tory function in active, normal children. Am. Rev. Respir. Dis. 137:313 - 320. Spencer, H. 1977. Pathology of the Lung, Excluding Pulmona~y Tuberculosis, 3d ed New York Perg~mon. 2 vols. Stahlhofen, W., J. Gebhart, J. Heyder, K. Philipson, and P. Camner. 1981. Intercompatison of regional deposi- tion of aerosol particles in the human respiratory tract and their longterm elimination. Exp. Lung Res. 2:131 - 139. Stalcup, S. A., G. M. Turino, and R. B. Mellins. 1982. Critical issues in the use of vasoactive substances to assess lung microvascular injury. Ann. N.Y. Acad. Sci. 384:435 - 457. Stanley, P. J., R. Wilson, M. A. Greenstone, I. S. Mackay, and P. J. Cole. 1985. Abnormal nasal mucociliary clearance in patients with rhinitis and its relationship to concommitent chest disease. Br. J. Dis. Chest. 79:77 - 82. Starkey, P. M., and A. J. Barrett. 1977. a2:macrogiobulin, a physiological regulator of proteinase activity, pp. 663 - 696. In A. J. Barrett, Ed. Proteinases in Mam- malian Cells and Tissues. Amsterdam: Elsevier North-Holland. Starr, T. B., and J. E. Gibson. 1984. The importance of delivered dose in quantitative risk estimation: Formaldehyde. Toxicologist 4:30. (Abstract.) Staub, N. C. 1974. Pulmonary edema. Physiol. Rev. 54:678 - 811. Staub, N. C. 1986. Clinical use of lung water measure- ments. Report of a workshop. Chest 90:588 - 594. Stern, R. M., K. Drenck, O. Lyngenbo, H. Dirksen, and S. Groth. 1986. Health, occupational exposure and thoracic magnetic moment of shipyard welders, pp. 403 - 407. In R. M. Stern, A. Berlin, A. C. Fletcher, J. Jarvisalo, Eds. Health Hazards and Biological Effects of Welding Fumes and Gases. International Congress Series, No. 676. Amsterdam: Excerpta Medical Stowers, S. J., P. L. Glover, S. H. Reynolds, L. R. Boone, R. R. Maronpot, and M. W. Anderson. 1987. Activa- tion of the K~s protooncogene in lung tumors from rats and mice chronically eyposed to tetranitrome- thane. Cancer Res. 47:3212 - 3219. Strumpf, I. J., M. K. Feld, M. J. Cornelius, B. A. Keogh, and R. G. Crystal. 1981. Safety of fiberoptic bron

162 choalveolar ravage in evaluation of interstitial lung disease. Chest 80:268 - 271. Stutts, M. J., and P. A. Bromberg. 1987. Effects of ozone on airway epithelial permeability and ion transport. Toxicol. Lett. 35:315 - 319. Stutts, M. J., R. C. Boucher, P. A. Bromberg, and J. T. Gatzy. 1981. Effects of ammonium and nitrate salts on ion transport across the excised canine trachea. Toxicol. Appl. Pharmacol. 60:91 - 105. Stutts, M. J., R. C. Boucher, and J. T. Gatzy. 1982. Effects of cadmium and zinc on canine tracheal bio- electric properties. Toxicol. Appl. Pharmacol. 64:147 - 154. Stutts, M. J., J. T. Gatzy, M. R. Knowles, C. U. Cotton, and R. C. Boucher. 1986. Effects of formaldehyde on bronchial ion Seaport. Toxicol. Appl. PharmacoL 82:360367. Sue, D. Y., A. Oren, J. E. Hansen, and K Wasserman. 1987. Diffusing capacity for carbon monoxide as a predictor of gas exchange during exercise. N. Engl. J. Med. 316:1301 - 1306. Sun, J. D., R. K Wolff, H. M. Aberman, and R. O. McClellan. 1983. Inhalation of 1-nitropyrene associ- ated with ultrafine insoluble particles or as a pure aerosol: A comparison of deposition and biological fate. Toxicol. Appl. Pharmacol. 69:185 - 198. Sun, J. D., R. K. Wolff, G. M. Kanapilly, and R. O. McClellan. 1984. Lung retention and metabolic fate of inhaled benzo~a~pyrene associated with diesel exhaust particles. T=icol. Appl. Pharmacol.73:4059. Sun, J. D., S. S. Ragsdale, J. M. Benson, and R. F. Hen- derson. 1985. Effects of the long-term depletion of reduced glutathione in mice administered L-buthio- nine-S,R-sulfoximine. Fundam. Appl. Toxicol. 5:913 - 919. Sutherland, M. W., M. Glass, J. Nelson, Y. Lyen, and H. J. Forman. 1985. Oxygen toxicity Loss of lung macrophage function without metabolite depletion. J. Free Radic. Biol. Med. 1:209 - 214. Swenberg, J. A., F. C. Richardson, L. Tyeryar, F. Deal, and J. Boucheron. 1986. The molecular dosimetry of DNA adducts formed by continuous exposure of rats to a~ylatinghepatocarcinogens. Prog. Exp.Tumor Res. 31:42 - 51. Tannenbaum, S. R., and P. L. Skipper. 1984. Biological aspects to the evaluation of risk: Dosimetry of car- cinogens in man. Fundam. Appl. Toxicol. 4:S367-S373. Taplin, G. V., D. P. Tashkin, S. K Chopra, O. E. Anselmi, D. Elam, B. Calvarese, A. Coulson, R. Detels, and S. N. Rokaw. 1977. Early detection of chronic ob- structive pulmonary disease us ng radionuclide lung-im- aging procedures. Chest 71:567 - 575. Task Group on Lung Dynamics. 1966. Deposition and retention models for internal dosimetry of the human respiratory tract. Health Phys. 12:173 - 207. Tate, R. M., and J. E. Repine. 1983. Neutrophils and the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 128:552 - 550. REFERENCES Taylor, S. M., H. Downed C. A. Hirshman, J. E. Peters, and D. Leon. 1983. Pulmonary uptake of mannitol as an index of changes in lung epithelia1 permeability. J. Appl. Physiol. 55:614 - 618. Teculescu, D. B., Q. T. Pham, and B. Hannhant. 1986. Tests of small airway dysfunction: Their correlation with the ~conventional" fling function tests. Eur. J. Respir. Dis. 69:175 - 187. Teisinger, J., and V. Fiserova-Bergerova. 1955. Valeur comparee de la determination des sulfates et du phenol contends dans ['urine pour ['evaluation de la concentration du benzene darts ['air. [Comparative value of det~minabon of urinary sulfates and phenol for evaluation of atmospheric benzene.] Arch. Mall Profess. 16:221 - 232. Thomas, P. D., and G. W. Hunninghake. 1987. Current concepts of the pathogenesis of sarcoidosis. Am Rev. Respir. Dis. 135:747 - 760. Thomas, P. S. 1983. Hybridization of denatured RNA transferred or dotted to nitrocellulose paper. Methods En~rmol. 100:255 - 266. Thomas, Y., R. Huchet, and D. Granjon. 1981. Him tamine-induced suppressor cells of lymphocyte mito- genic response. Cell. Immunol. 59:268~275. Thomson,M. L., end D. Pavia. 1974. Particle penetration and clearance in the human lung: Results in healthy subjects and subjects with chronic bronchitis. Arch. Environ. Health 29:214 - 219. Thomson, M. L., and M. D. Short. 1969. Mucocilia~y Unction in health, chronic obstructive ai}w~,r disease, and asbestosis. J. Appl. Physiol. 26:535 - 539. Thrall, R. S., J. R. McCormick, R. M. Jack, R. A. MA Reynolds, and P. A. Ward 1979. Bleomycin-induced pulmonary fibrosis in the rat: Inhibition by indo- methacin. Am. J. Pathol. 95:117 - 130. Tingley, D. T., M. Manning, L. C. Grothaus, and W. F. Burns. 1979. The influence of light and tempera- ture on isoprene emission rates from live oak. Physiol. Plant. 47:112 - 118. Todorovich, L., D. Johnson, P. Ranger, F. Keeley, and M. Rabinovitch. 1986. Contribution of elastin and collagen to the pathogenesis of monocrotaline induced pulmonary hypertension. Fed. Proc. 45:696. (Ab- stract.) Toews, G. B., W. C. Vial, M. M. Dunn, P. Guzzetta, G. Nunez, P. Stastny, and M. F. Lipscomb. 1984. The accessory cell function of human alveolar macro- phages in Specific T cell proliferation. J. Immunol. 132:181 - 186. Togias, A. G., R M. Naclerio, S. P. Peters, I. Nimm~d- da, D. Proud, A. Kagey-Sobotka, N. F. Adkinson, Jr., P. S. Norman, and L. M. Lichtenstein. 1986. Local generation of sulfidopeptide leukotrienes upon nasal provocation with cold dry air. Am. Rev. Respir. Dis. 133:1133 - 1137. Toigo, A., J. J. Imarisio, H. Murmall, and M. N. Lepper. 1963. Clearance of large carbon particles from the human tracheobronchial tree. Am. Rev. Respir. Dis. 87:487 - 492.

REFERENCES Tomicka M., S. Ida, Y. Shinoh, T. Ishihara, and T. Taki- shima. 1984. Mast cells in bronchoalveolar lumen of patients with bronchial asthma. Am. Rev. Respir. Dis. 129:1000 1005. Toomes, H., I. Vogt-Moykopf, W. D. Helter, and H. Ostertag. 1981. Measurement of mucociliary clearance in smokers and nonsmokers using a bronchoscopic video-technical method. Lung 159:27 - 34. Tornqvist, M., S. Osterman-Golkar, A. Kautiainen, S. Jensen, P. B. Farmer, and L. Ehrenberg. 1986. Tissue doses of ethylene chide in cigarette smokers determined from adduct levels in hemoglobin. Carcinogenesis 7:1519 - 1521. U.S. Environmental Protection Agency. 1984. Air Quality Criteria for Ozone and Other Photochemical Oxidants, Vol. IV. Washington, D.C.: U.S. Environmental Protection Agency. Unanue, E. R., D. I. Belier, C. Y. Lu, and P. M. Allen. 1984. Antigen presentation: Comments on its regula- tion and mechanism. J. Immunol. 132:1 - 5. Utell, M. J., P. E. Morrow, and R. W. Hyde. 1984. Airway reactivity to sulfate and sulfuric acid aerosols in normal and asthmatic subjects. J. Air Pollut. Con- trol Assoc. 34:931 - 935. Utell, M. J., P. E. Morrow, M. A. Bauer, G. Oberdorster, D. A. Weber, and R. W. Hyde. 1985. Epithelial per- meabilityfollou~ng ozoneinhalationin healthysubjects. Am. Rev. Respir. Dis. 131:A171. (Abstract.) Valberg, P. A., and J. D. Brain. 1979. Generation and use of three types of iron-oxide aerosol. Am. Rev. Respir. Dis. 120:1013 - 1024. Valenti, S., A. Scordamaglia, P. Crimi, and C. Mereu. 1982. Bronchoalveolar ravage and transbronchial lung biopsy in sarcoidosis and extrinsic allergic alveolitis. Eur. J. Respir. Dis. 63:564 - 569. Van oud Alblas, A. B., and R. van Furth. 1979. Origin, kinetics and characteristics of pulmonary macrophages in the normal steady state. J. Exp. Med 149.1504 1518. Van Ree, J. H. L., and H. A. E. Van Dishoeck. 1962. Some investigations on nasal ciliary activity. Pract. Otorhinolaryngol. 24:383 - 390. Vaughan, T. R., Jr., L. F. Jennelle, and T. R. Lewis. 1969. Long-term exposure to low levels of air pol- lutants. Effects on pulmonary function in thebeagle. Arch. Environ. Health 19:45 - 50. Venet, A., A. J. Hance, C. Saltini, B. W. S. Robinson, and R. G. Crystal. 1985. Enhanced alveolar macro- phage-mediated antigen-induced T-tmphocyte proli- feration in sarcoidosis. J. Clin. Invest. 75:293 - 301. Wagenvoort, C. A., and N. Wagenvoort. 1977. Pathology of Pulmonary Hypertension. New York: John Wiley & Sons. 345 pp. Wagner, J. C. 1965. The sequelae of exposure to asbestos dust. Ann. N.Y. Acad. Sci. 132:691 - 695. Wallace, L. A. 1987. The Total Exposure Assessment Methodology (TEAM) Stupor. Summary end Analysis: Volume I. EPA 600/6-87/002a. Washington, D. C.: U.S. Environmental Protection Agency, Office of Acid Depositon, Environmental Monitonng and 163 Quality Assurance. Wanner, A. 1977. Clinical aspects of mucociliary trans- port. Am. Rev. Respir. Dis. 116:73 - 125. Wanner, A. 1980. Pulmonary defense mechanisms: Mu~ilia~ clearance, pp. 325 356. In D. H. Simmons, Ed. Current Pulmonology, Vol. 2. Boston: Houghton Mifflin. Ware, J. H., D. W. Dockery, A. Spiro, III, F. E. Speizer, and B. G. Ferris, Jr. 1984. Pass*e smoking, gas cooking, and respiratory health of children living in six cities. Am. Rev. Respir. Dis. 129:366 - 74. Warheit, D. B., L. Y. Chang, L. H. Hill, G. E. R. Hook, J. D. Crapo, and A. R. Brody. 1984. Pulmonary macrophage accumulation and asbestos-induced lesions at sites of fiber deposition. Am. Rev. Respir. Dis. 129:301 - 310. Warheit, D. B., G. George, L. H. Hill, R. Snyderman, and A. R. Brody. 1985. Inhaled asbestos activates a complement-dependent chemoattractant for micro- phages. Lab. Invest. 52:505 - 514. Warheit, D. B., L. H. Hill, G. George, and A. R. Brody. 1986. Time course of chemotactic factor generation and the corresponding macrophage response to asbes- tos inhalation. Am. Rev. Respir. Dis. 134:128 - 133. Warheit, D. B., L. H. Overby, A. George, and A. R. Brody. 1988. Pulmonary macrophages are attracted to inhaled particles through complement activation. Exp. Lung Res. 14:51 - 66. Warner, J., M. M. Pienkowski, M. Plaut, P. S. Norman, and L. M. Lichtenstein. 1986. Identification of his- tamine releasing factorts) in the late phase of cuta- neous IgE-mediated reactions. J. Immunol. 136:2583 - 2587. Wasserman, K. 1985. An integrative approach to the non-invasive assessment of cardiovascular and respira- tory function during exercise. Workshop on Physical Fitness and Activity Assessment in NCHS General Population Surveys, National Center for Health Statis- tics, June. Wasserman, K., B. J. Whipp, and J. A. Davis. 1981. Respiratory physiology of exercise: Metabolism, gas exchange, end ventilators control. Int. Rev. Physiol. 23:149 - 211. Wasserman, K, J. E. Hansen, D. Y. Sue, and B. J. Whipp. 1987. Principles of Exercise Toting andInteIpretation. Philadelphia: Lea and Febiger. Weibel, E. R. 1979. Stereological Methods: Practical Methods for Biological Morphomet~y, Vol. 1. New York: Academic Press. Weinberger, S. E., J. A. Kelman, N. A. Elson, R. C. Young, Jr., H. Y. Reynolds, J. D. Fulmer, and R. G. Coal. 1978. Bronchoalveolar ravage in interstitial lung disease. Ann. Intern. Med. 89:459 - 466. Weiss, J. W., J. M. Drazen, N. Coles, E. R. McFadden, Jr., P. F. Weller, E. J. Corey, R. A. Lewis, and K. F. Austen. 1982. Bronchoconstrictor effects of leuko- triene C in humans. Science 216:196 - 198. Weiss, S. T., I. B. Tager, F. E. Speizer, and B. Rosner. 1980. Persistent wheeze: Its relation to respiratory

164 illness, cigarette smoking, and level of pulmonary function in a population sample of children. Am. Rev. Respir. Dis. 122:697 - 707. Weiss, S. T., I. B. Tager, J. W. Weiss, A. Munoz, F. E. Speizer, and R. H. Ingram. 1984. ALways responsive- ness in a population sample of adults and children. Am. Rev. Respir. Dis. 129:898 - 902. Weissler, J. C., C. R. Lyons, M. F. Lipscomb, and G. B. Toews. 1986. Human pulmonary macrophages: Functional comparison of cells obtained from whole lung and bybronchoalveolar ravage. Am. Rev. Respir. Dis. 133:473 - 477. Weller, P. F., C. W. Lee, D. W. Foster, E. J. Corey, K. F. Austin, and R. A. Lewis. 1983. Generation and metabolism of 5-lipaxygenase pathway leukotrienes by human eosinophils: Predominant production of leukotriene C4. Proc. Natl. Acad. Sci USA 80:7626 - 7630. Wewers, M. D., S. I. Rennard, A. J. Hance, P. B. Bitter- man, and R. G. Crystal. 1984. Normal human alveolar macrophages obtained by bronchoalveolar ravage have a limited capacity to release interleukin-l. J. Clin. Invest. 74:2208 - 2218. Wexter, H. R., R. L. Nicholson, F. S. Prato, L. S. Carey, S. Vinitski, and L. Reese. 1985. Quantitation of lung water by nuclear magnetic resonance imaging. A preliminary study. Invest. Radiol. 20:583 - 590. White, R. T., D. Damm, J. Miller, K. Spratt, J. Schilling, S. Hawgood, B. Benson, and B. Cordell. 1985. Isola- tion and characterization of the human pulmona~y surfactant apoprotein gene. Nature 317:361 - 363. Williams, W. J., and W. R. Williams. 1983. Value of beryllium lymphocyte transformation tests in chronic beryllium disease andinpotentiallyexposedworkers. Thorax 38:41 - 44. Williams, W. R., and W. J. Williams. 1982. Development of beryllium lymphocyte transformation tests in chronic beryllium disease. Int. Arch. Aller~y Appl. humunol. 67:175 - 180. Williamson, S. J., and L. Kaufman. 1981. Biomagnetism topical review. J. Magn. Magn. 22:129 - 201. Willis, R. J., and C. C. Kratzing. 1976. Extracellular ascorbic acid in lung. Biochim. Biophys. Acta 444:108 - 111. Wilson, J. T., P. F. Milner, M. E. Summer, F. S. Nallaseth, H. E. Fadel, R. H. Reindollar, P. G. McDonough, and L. B. Wilson. 1982. Use of restriction endonucle- ases for mapping the allele for betas-globin. Proc. Natl. Acad. Sci. USA 79:3628 - 3631. Wilson,M. R., H. R. Gaumer, end d. E. Salvaggio. 1977. Activation of the alternate complement pathway and generation of chemotactic factors by asbestos. J. Allergy Clin. Immunol. 60:218 - 222. Witz, G., M. A. Amoruso, and B. D. Goldstein. 1983. Effect of ozone on alveolar macrophage function: Membrane ~ynamic properties, pp. 263 - 272. In S. D. Lee, M. G. Mustafa, and M. A. Mehlman, Eds. Proceedings of the Symposium on the Biomedical Effects of Ozone and Related Photochemical Oxidants, REFERENCES March 1982, Pinehurst, N.C. Advances in Modern Environmental Toxicology, Vol. 5. Princeton, NJ.: Princeton Scientif~c Publishers. Wogan, G. N. 1988. Methods for detecting DNA damag- ingagentsinhumans. Summa~y Methods. IARC Sci. Publ. 89:9 - 12. Wogan, G. N., and N. J. Gorelick. 1985. Chemical and biochemical dosime~y of exposure to genota~c chemi- cals. Environ. Health Perspect. 62:5 - 18. Wolff, M. S., J. Thornton, A. Fischbein, R. Lilis, and I. J. Selikoff. 1982. Disposition of polychlorinated biphenyl congeners in occupationaDy exposed persons. Toxicol. Appl. Pharmacol. 62:294 - 306. Wolff, R. K 1986. Effects of airborne pollutants on mucocilia~y clearance. Environ. Health Perspect. 66:223 - 237. Wolff, R. K., B. A. Muggenberg, and S. A. Silbaugh. 1981. Effect of 03 and 0.9 micron sulfuric acid aero- sols on tracheal mucous clearance in beagle dogs. Am. Rev. Respir. Dis. 123:291 - 294. Wolff, R. K., B. A. Muggenburg, S. A. Silbaugh, R. L. Carpenter, J. D. Rowatt, and J. O. Hill. 1982. Lung Clearance Mechanisms Following Inhalation of Acid Sulfates. Report LMF-99. Albuquerque, NM.: Inhalation Toxicology Research Institute, Lovelace Biomedical and Environmental Research Institute. Available from NTIS. Wolff, R. K., R. F. Henderson, A. F. Eidson, J. A. Pick- rell, S. J. Rothenbeq~, and F. F. Hahn. 1988. Toxicity of gallium omde particles follo~nng a ~week inhalation exposure. J. Appl. Toxicol. 8:191 - 199. Wolff, R. K., J. A. Bond, J. D. Sun, R. F. Henderson, J. R. Harkema, W. C. Griff~th, J. L. Mauderly, and R. O. McClellan. 1989. Effects of adsorption of benzotaipyrene onto carbon black particles on levels of DNA adducts in lungs of rats exposed by inhalation. Toxicol. Appl. Pharmacol. 97:289 - 299. Wollmer, P., C. G. Rhodes, and J. M. B. Hughes. 1984. Regional extravascular density and fractional blood volume of the lung in interstitial disease. Thorax 39:286 293. Woo, S. L. C., A. S. Lidsky, F. Guttler, T. Chandra, and K J. H. Robson. 1983. Cloned human phenylalanine }~rdro~ylase gene allows prenatal diagnosis and carrier detection of classical phenyLketonuria. Nature 306:151 - 155. Wood, P. B., E. Nagy, and F. G. Pearson. 1973. Meas- urement of mucocilia~y clearance from the lower respirato~y tract of normal dogs. Can. Anaesth. Soc. J. 20:192 - 206. Woolco~, A. J., N. J. Vincent, and P. T. Maddem. 1969. Frequency dependence of compliance as a test for obstruction in the small ainvays. J. Clin. Invest. 48:1097 - 1106. Wooten, F. T., W. W. Warring, M. J. Wegmann, W. F. Anderson, and J. D. Conley. 1978. Methods for respiratory sound analysis. Med. ~um. 12:254 257. Yanagisawa, Y., H. Nishimura, H. Matsuki, F. Osaka, and H. Kasuga. 1986. Personal exposure and health

REFERENCES effect relationship for NO2 with urinary hydroQyproline to creatinine ratio as indicator. Arch. Env. Health 41:41 - 48. Yeates, D. B., M. Aspin, H. Levison, M. T. Jones, and A. C. Bryan. 1975. Mucociliary tracheal transport rates in man. J. Appl. Physiol. 39:487 - 495. Young, K. R., and H. Y. Reynolds. 1984. Bronchoal- veolar washings: Proteins and cells from normal lung,;, pp. 157 - 173. In J. Bienenstock, Ed. Immunology of the Lung and Upper Respiratory Tract. New York: McGraw-Hill. Zarbl, H., S. Sukomar, A. V. Arthur, D. Martin-Zanca, and M. Barbacid. 1985. Direct mutagenesis of the HA-ras-1 oncogenesbyN-nitroso-N-methylurea during initiation of mamrnarycarcinogenesisin rats. Nature 315:382 - 385. 165 Zarins, L. P., and J. L. Clausen. 1982. Body plethysmo- graphy, pp. 141 - 153. In J. L. Clausen, Ed Pulmonary Function T=ing Guidelines and Concierges Emu meet, Methods, and Normal Values. New York: Academic Press. Zavala, D. C. 1978. Flexible Fiberoptic Bronchoscopy. A Trailiing Handbook. Iowa City University of Iowa. 165 pp. Zeiss, C. R., P. Wolkonsky, R. Chacon, P. A. Tuntland, D. Levitz, J. J. Prunzansky, and R. Patterson. 1983. Syndromes in workers exposed to bimetallic ar~ydride: Alongitudinal clinical and immunologic study. Ann. Intern. Med. 98:8 - 12. Zlatkis, A., R. S. Brazell, and C. F. Poole. 1981. The role of organic volatile profiles in clinical diagnosis. Clin. Chem. 27:789 - 797.

Next: Biographies »
Biologic Markers in Pulmonary Toxicology Get This Book
×
Buy Paperback | $50.00 Buy Hardback | $50.00
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

Biologic markers—indicators of biological exposure or change—offer the promise of early detection of disease caused by environmental exposure. Researchers have used these markers to discover indications of pulmonary damage from low-level ozone, a finding with serious implications for health professionals and environmental regulators. Biologic Markers in Pulmonary Toxicology is a comprehensive study of this use of biologic markers. Focusing on the respiratory tract as an entryway for airborne pollutants, this volume reviews new ways of measuring markers, the need for markers to indicate dose or exposure levels, noninvasive respiratory function tests for use with healthy humans to detect sensitivity to inhaled pollutants, approaches to evaluating markers down to the cellular and biochemical levels, and more.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  6. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  7. ×

    View our suggested citation for this chapter.

    « Back Next »
  8. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!